<SEC-DOCUMENT>0000950103-25-012614.txt : 20251001
<SEC-HEADER>0000950103-25-012614.hdr.sgml : 20251001
<ACCEPTANCE-DATETIME>20251001093440
ACCESSION NUMBER:		0000950103-25-012614
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20251001
DATE AS OF CHANGE:		20251001

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIGROUP INC
		CENTRAL INDEX KEY:			0000831001
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				521568099
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327
		FILM NUMBER:		251362755

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		2125591000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS GROUP INC
		DATE OF NAME CHANGE:	19950519

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS INC
		DATE OF NAME CHANGE:	19940103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMERICA CORP /NEW/
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citigroup Global Markets Holdings Inc.
		CENTRAL INDEX KEY:			0000200245
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		EIN:				112418067
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327-01
		FILM NUMBER:		251362756

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212-816-6000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CITIGROUP GLOBAL MARKETS HOLDINGS INC
		DATE OF NAME CHANGE:	20030404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON SMITH BARNEY HOLDINGS INC
		DATE OF NAME CHANGE:	19971128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp235294_424b2-us2515605d.htm
<DESCRIPTION>PRELIMINARY PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: red">The information in this preliminary
pricing supplement is not complete and may be changed. A registration statement relating to these notes has been filed with the Securities
and Exchange Commission. This preliminary pricing supplement and the accompanying product supplement, underlying supplement, prospectus
supplement and prospectus are not an offer to sell these notes, nor are they soliciting an offer to buy these notes, in any state where
the offer or sale is not permitted.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: red">SUBJECT TO COMPLETION, DATED OCTOBER
1, 2025</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Pricing Supplement No. 2025-USNCH[ ] to Product Supplement No. EA-04-10
dated March 7, 2023,</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Underlying Supplement No. 11 dated March 7, 2023, Prospectus Supplement
and Prospectus each dated March 7, 2023</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Filed Pursuant to Rule 424(b)(2)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Registration Statement Nos. 333-270327 and 333-270327-01</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Dated October<FONT STYLE="color: white">---</FONT>, 2025</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Citigroup Global Markets Holdings Inc. $---- Trigger Callable Contingent
Yield Notes (with daily coupon observation)</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Linked to the Least Performing of the S&amp;P 500<SUP>&reg;</SUP>
Index, the Nasdaq-100 Index<SUP>&reg;</SUP> and the Russell 2000<SUP>&reg;</SUP> Index Due On or About January 4, 2029</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>All payments due on the notes are fully and unconditionally guaranteed
by Citigroup Inc.</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%; font-size: 12pt"><FONT STYLE="font-size: 10pt; color: white"><B>Investment Description</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Trigger Callable Contingent Yield Notes (the &ldquo;<B>notes</B>&rdquo;)
are unsecured, unsubordinated debt obligations of Citigroup Global Markets Holdings Inc. (the &ldquo;<B>issuer</B>&rdquo;), guaranteed
by Citigroup Inc. (the &ldquo;<B>guarantor</B>&rdquo;), linked to the <B>least performing</B> of the S&amp;P 500<SUP>&reg;</SUP> Index,
the Nasdaq-100 Index<SUP>&reg;</SUP> and the Russell 2000<SUP>&reg;</SUP> Index (each, an &ldquo;<B>underlying</B>&rdquo;).&nbsp;&nbsp;The
notes will pay a contingent coupon on each quarterly coupon payment date if, <B>and only if</B>, the closing levels of <B>all</B> the
underlyings on each trading day during the applicable quarterly observation period are greater than or equal to their respective coupon
barriers.&nbsp;&nbsp;If the closing level of <B>any</B> underlying on <B>any</B> trading day during an observation period is less than
its coupon barrier, no contingent coupon will be paid on the related coupon payment date.&nbsp;&nbsp;On any coupon payment date prior
to the maturity date, the issuer may, in its sole discretion, call the notes in whole, but not in part, and pay you the stated principal
amount per note plus any contingent coupon otherwise due on such coupon payment date and no further amounts will be owed to you.&nbsp;&nbsp;If
the notes have not previously been called by the issuer prior to maturity and the final underlying level of the least performing underlying
is greater than or equal to its downside threshold, you will receive the stated principal amount of your notes at maturity plus any contingent
coupon payment otherwise due on the maturity date.&nbsp;&nbsp;However, if the notes have not been called prior to maturity and the final
underlying level of the least performing underlying is less than its downside threshold, you will receive less than the stated principal
amount of your notes at maturity, resulting in a loss that is proportionate to the decline in the closing level of the least performing
underlying from the trade date to the final valuation date, up to a 100% loss of your investment.&nbsp;&nbsp;The &ldquo;<B>final underlying
level</B>&rdquo; for each underlying is the closing level of such underlying on the final valuation date and the &ldquo;<B>least performing
underlying</B>&rdquo; is the underlying with the lowest underlying return as measured from the trade date to the final valuation date.&nbsp;&nbsp;<B>Investing
in the notes involves significant risks.&nbsp;&nbsp;You may lose a substantial portion or all of your initial investment if the notes
are not called by the issuer in its sole discretion on any coupon payment date prior to the maturity date and the final underlying level
of the least performing underlying is less than its downside threshold.&nbsp;&nbsp;The payment at maturity on the notes is based <U>solely</U>
on the performance of the least performing underlying.&nbsp;&nbsp;You will not benefit in any way from the performance of the better performing
underlyings.&nbsp;&nbsp;You will therefore be adversely affected if <U>any</U> underlying performs poorly, regardless of the performance
of the other underlyings.&nbsp;&nbsp;You will not receive dividends or other distributions paid on any stocks included in the underlyings
or participate in any appreciation of any underlying.&nbsp;&nbsp;The contingent repayment of the stated principal amount applies only
if you hold the notes to maturity or earlier call by the issuer.&nbsp;&nbsp;Any payment on the notes, including any repayment of the stated
principal amount, is subject to the creditworthiness of the issuer and the guarantor and is not, either directly or indirectly, an obligation
of any third party. If the issuer and the guarantor were to default on their payment obligations, you may not receive any amounts owed
to you under the notes and you could lose your entire investment.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 69%; background-color: #788D41; font-size: 12pt"><FONT STYLE="font-size: 10pt; color: white"><B>Features</B></FONT></TD>
    <TD STYLE="width: 2%; font-size: 12pt">&nbsp;</TD>
    <TD STYLE="width: 29%; background-color: #788D41; font-size: 12pt"><FONT STYLE="font-size: 10pt; color: white"><B>Key Dates<SUP>1</SUP></B></FONT></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<DIV STYLE="float: left; width: 69%">

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Wingdings; font-size: 10pt">q</FONT></TD>
    <TD STYLE="width: 95%"><FONT STYLE="font-size: 10pt"><B>Contingent Coupon</B> &mdash; We will pay you a contingent coupon on each quarterly coupon payment date if, <B>and only if,</B> the closing levels of <B>all</B> the underlyings on each trading day during the applicable quarterly observation period are greater than or equal to their respective coupon barriers.&nbsp;&nbsp;Otherwise, no contingent coupon will be paid on that quarterly coupon payment date.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">q</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><B>Issuer Callable </B>&mdash; On any coupon payment date prior to the maturity date, the issuer may, in its sole discretion, call the notes in whole, but not in part, and pay you the stated principal amount per note plus any contingent coupon otherwise due on such coupon payment date.&nbsp;&nbsp;If the notes are not called, investors may have full downside market exposure to the least performing underlying at maturity.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">q</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><B>Downside Exposure with Contingent Repayment of Principal at Maturity </B>&mdash; If the notes have not previously been called by the issuer prior to maturity and the final underlying level of the least performing underlying is greater than or equal to its downside threshold, you will receive the stated principal amount of your notes at maturity plus any contingent coupon payment otherwise due on the maturity date.&nbsp;&nbsp;However, if the notes have not been called prior to maturity and the final underlying level of the least performing underlying is less than its downside threshold, you will receive less than the stated principal amount of your notes at maturity, resulting in a loss that is proportionate to the decline in the closing level of the least performing underlying from the trade date to the final valuation date, up to a 100% loss of your investment.&nbsp;&nbsp;<B>Any payment on the notes is subject to the creditworthiness of the issuer and guarantor. If the issuer and the guarantor were to default on their obligations, you might not receive any amounts owed to you under the notes and you could lose your entire investment.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</DIV>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<DIV STYLE="float: right; width: 29%">

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47%"><FONT STYLE="font-size: 10pt">Trade date</FONT></TD>
    <TD STYLE="width: 53%; padding-left: 13.7pt; text-indent: -13.7pt"><FONT STYLE="font-size: 10pt">October 1, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Settlement date</FONT></TD>
    <TD STYLE="padding-left: 13.7pt; text-indent: -13.7pt"><FONT STYLE="font-size: 10pt">October 3, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Observation period end dates</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Quarterly, beginning on January 2, 2026</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(See page PS-6)</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Final valuation date<SUP>2</SUP></FONT></TD>
    <TD STYLE="padding-left: 13.7pt; text-indent: -13.7pt"><FONT STYLE="font-size: 10pt">January 2, 2029</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 13.7pt; text-indent: -13.7pt"><FONT STYLE="font-size: 10pt">Maturity date</FONT></TD>
    <TD STYLE="padding-left: 13.7pt; text-indent: -13.7pt"><FONT STYLE="font-size: 10pt">January 4, 2029</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 13.7pt"><SUP>1</SUP></TD><TD>Expected</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 13.7pt"><FONT STYLE="background-color: white"><SUP>2</SUP></FONT></TD><TD>See page PS-4 for additional details.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

</DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>NOTICE TO INVESTORS: <FONT STYLE="text-transform: uppercase">The
notes are significantly riskier than conventional debt INSTRUMENTS. THE ISSUER IS NOT NECESSARILY OBLIGATED TO REPAY THE STATED PRINCIPAL
AMOUNT OF THE NOTES AT MATURITY, AND the notes CAN have downside MARKET risk SIMILAR TO the LEAST PERFORMING UNDERLYING.&nbsp;&nbsp;This
MARKET risk is in addition to the CREDIT risk INHERENT IN PURCHASING A DEBT OBLIGATION OF CITIGROUP GLOBAL MARKETS HOLDINGS INC. THAT
IS GUARANTEED BY CITIGROUP INC.&nbsp;&nbsp;You should not PURCHASE the notes if you do not understand or are not comfortable with the
significant risks INVOLVED in INVESTING IN the notes.</FONT></B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>YOU SHOULD CAREFULLY CONSIDER THE RISKS DESCRIBED UNDER &lsquo;&lsquo;SUMMARY
RISK FACTORS&rsquo;&rsquo; BEGINNING ON PAGE PS-7 OF THIS PRICING SUPPLEMENT AND UNDER &lsquo;&lsquo;RISK FACTORS RELATING TO THE SECURITIES&rsquo;&rsquo;
BEGINNING ON PAGE EA-7 OF THE ACCOMPANYING PRODUCT SUPPLEMENT BEFORE PURCHASING ANY NOTES. EVENTS RELATING TO ANY OF THOSE RISKS, OR
OTHER RISKS AND UNCERTAINTIES, COULD ADVERSELY AFFECT THE MARKET VALUE OF, AND THE RETURN ON, YOUR NOTES. YOU MAY LOSE SOME OR ALL OF
YOUR INITIAL INVESTMENT IN THE NOTES.&nbsp;&nbsp;THE NOTES WILL NOT BE LISTED ON ANY SECURITIES EXCHANGE AND MAY HAVE LIMITED OR NO LIQUIDITY.</B></P></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%; font-size: 12pt"><FONT STYLE="font-size: 10pt; color: white"><B>Notes Offering</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We are offering Trigger Callable Contingent Yield Notes Linked to the
Least Performing of the S&amp;P 500<SUP>&reg;</SUP> Index, the Nasdaq-100 Index<SUP>&reg;</SUP> and the Russell 2000<SUP>&reg;</SUP>
Index.&nbsp;&nbsp;The initial underlying levels, coupon barriers and downside thresholds will be determined on the trade date. The notes
are our unsecured, unsubordinated debt obligations, guaranteed by Citigroup Inc., and are offered for a minimum investment of 100 notes
at the issue price described below.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 16%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Underlyings</B></FONT></TD>
    <TD STYLE="width: 15%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Contingent Coupon Rate</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 16%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Initial Underlying Levels</B></FONT></TD>
    <TD STYLE="width: 19%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Coupon Barriers</B></FONT></TD>
    <TD STYLE="width: 23%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Downside Thresholds</B></FONT></TD>
    <TD STYLE="width: 11%; text-align: center"><FONT STYLE="font-size: 10pt"><B>CUSIP/ISIN</B></FONT></TD></TR>
  <TR>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">S&amp;P 500<SUP>&reg;</SUP> Index</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(Ticker: SPX)</P></TD>
    <TD ROWSPAN="3" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">9.50% per annum</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">, which is 65% of the applicable initial underlying level</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">, which is 60% of the applicable initial underlying level</FONT></TD>
    <TD ROWSPAN="3" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">17333F751 / US17333F7511</FONT></TD></TR>
  <TR>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">Nasdaq-100 Index<SUP>&reg;</SUP></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(Ticker: NDX)</P></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">, which is 65% of the applicable initial underlying level</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">, which is 60% of the applicable initial underlying level</FONT></TD></TR>
  <TR>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">Russell 2000<SUP>&reg;</SUP> Index</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(Ticker: RTY)</P></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">, which is 65% of the applicable initial underlying level</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">, which is 60% of the applicable initial underlying level</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>See &ldquo;Additional Terms Specific to the Notes&rdquo; in this
pricing supplement.&nbsp;&nbsp;The notes will have the terms specified in the accompanying product supplement, prospectus supplement
and prospectus, as supplemented by this pricing supplement. </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Neither the Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;)
nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing
supplement or the accompanying product supplement, underlying supplement, prospectus supplement and prospectus. Any representation to
the contrary is a criminal offense. The notes are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance
Corporation or any other governmental agency.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 24%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 28%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Issue Price<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 23%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Underwriting Discount<SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 25%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Proceeds<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT>to<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT>Issuer</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt">Per note</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$10.00</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$0.10</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$9.90</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt">Total</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$ </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">(1) Citigroup Global Markets Holdings Inc. currently
expects that the estimated value of the notes on the trade date will be at least $9.66 per note, which will be less than the issue price.&nbsp;&nbsp;The
estimated value of the notes is based on proprietary pricing models of Citigroup Global Markets Inc. (&ldquo;<B>CGMI</B>&rdquo;) and
our internal funding rate.&nbsp;&nbsp;It is not an indication of actual profit to CGMI or other of our affiliates, nor is it an indication
of the price, if any, at which CGMI or any other person may be willing to buy the notes from you at any time after issuance. See &ldquo;Valuation
of the Notes&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">(2) The underwriting discount is $0.10 per note.
CGMI, acting as principal, expects to purchase from Citigroup Global Markets Holdings Inc., and Citigroup Global Markets Holdings Inc.
expects to sell to CGMI, the aggregate stated principal amount of the notes set forth above for $9.90 per note. UBS Financial Services
Inc. (&ldquo;<B>UBS</B>&rdquo;), acting as agent for sales of the notes, expects to purchase from CGMI, and CGMI expects to sell to UBS,
all of the notes for $9.90 per note. UBS will receive an underwriting discount of $0.10 for each note it sells in this offering.&nbsp;&nbsp;UBS
proposes to offer the notes to the public at a price of $10.00 per note.&nbsp;&nbsp;For additional information on the distribution of
the notes, see &ldquo;Supplemental Plan of Distribution&rdquo; in this pricing supplement.&nbsp;&nbsp;In addition to the underwriting
discount, CGMI and its affiliates may profit from expected hedging activity related to this offering, even if the value of the notes
declines.&nbsp;&nbsp;See &ldquo;Use of Proceeds and Hedging&rdquo; in the accompanying prospectus.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-indent: 0in; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Citigroup Global Markets Inc.</B></FONT></TD>
    <TD STYLE="width: 50%; text-align: right; text-indent: 0in; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>UBS Financial Services Inc.</B></FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt; color: white"><B>Additional Terms Specific to the Notes</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The terms of the notes are set forth in the accompanying product supplement,
prospectus supplement and prospectus, as supplemented by this pricing supplement.&nbsp;&nbsp;The accompanying product supplement, prospectus
supplement and prospectus contain important disclosures that are not repeated in this pricing supplement.&nbsp;&nbsp;For example, certain
events may occur that could affect whether you receive a contingent coupon payment on a coupon payment date and whether you are repaid
the stated principal amount of your notes at maturity.&nbsp;&nbsp;These events and their consequences are described in the accompanying
product supplement in the sections &ldquo;Description of the Securities&mdash;Consequences of a Market Disruption Event; Postponement
of a Valuation Date&rdquo; and &ldquo;Description of the Securities&mdash;Certain Additional Terms for Securities Linked to an Underlying
Index&mdash;Discontinuance or Material Modification of an Underlying Index,&rdquo; and not in this pricing supplement.&nbsp;&nbsp;The
accompanying underlying supplement contains important disclosures regarding the underlyings that are not repeated in this pricing supplement.&nbsp;&nbsp;It
is important that you read the accompanying product supplement, underlying supplement, prospectus supplement and prospectus together with
this pricing supplement before you decide whether to invest in the notes.&nbsp;&nbsp;Certain terms used but not defined in this pricing
supplement are defined in the accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You may access the accompanying product supplement, underlying supplement,
prospectus supplement and prospectus on the SEC website at www.sec.gov as follows (or if such address has changed, by reviewing our filings
for the relevant dates on the SEC website):</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 14.4pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>Product Supplement No. EA-04-10 dated March 7, 2023:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 14.45pt; text-indent: 0in"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003814/dp190219_424b2-coba0410.htm">https://www.sec.gov/Archives/edgar/data/200245/000095010323003814/dp190219_424b2-coba0410.htm</A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 14.45pt; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 14.4pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>Underlying Supplement No. 11 dated March 7, 2023:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 14.45pt; text-indent: 0in"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003815/dp189981_424b2-us11.htm">https://www.sec.gov/Archives/edgar/data/200245/000095010323003815/dp189981_424b2-us11.htm</A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 14.45pt; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 14.4pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>Prospectus Supplement and Prospectus each dated March 7, 2023:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in"><A HREF="https://www.sec.gov/Archives/edgar/data/831001/000119312523063080/d470905d424b2.htm">https://www.sec.gov/Archives/edgar/data/831001/000119312523063080/d470905d424b2.htm</A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You may revoke your offer to purchase the notes at any time prior to
the time at which we accept such offer by notifying the applicable agent.&nbsp;&nbsp;We reserve the right to change the terms of, or reject
any offer to purchase, the notes on or prior to the trade date.&nbsp;&nbsp;The applicable agent will notify you in the event of any material
changes to the terms of the notes, and you will be asked to accept such changes in connection with your purchase of the notes. You may
also choose to reject such changes, in which case the applicable agent may reject your offer to purchase the notes.&nbsp;&nbsp;References
to &ldquo;Citigroup Global Markets Holdings Inc.,&rdquo; &ldquo;Citigroup,&rdquo; &ldquo;we,&rdquo; &ldquo;our&rdquo; and &ldquo;us&rdquo;
refer to Citigroup Global Markets Holdings Inc. and not to any of its subsidiaries.&nbsp;&nbsp;References to &ldquo;Citigroup Inc.&rdquo;
refer to Citigroup Inc. and not to any of its subsidiaries.&nbsp;&nbsp;In this pricing supplement, &ldquo;notes&rdquo; refers to the Trigger
Callable Contingent Yield Notes Linked to the Least Performing of the S&amp;P 500<SUP>&reg;</SUP> Index, the Nasdaq-100 Index<SUP>&reg;</SUP>
and the Russell 2000<SUP>&reg;</SUP> Index that are offered hereby, unless the context otherwise requires.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>This pricing supplement, together with the documents listed above,
contains the terms of the notes and supersedes all other prior or contemporaneous oral statements as well as any other written materials
including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, brochures
or other educational materials of ours.&nbsp;&nbsp;The description in this pricing supplement of the particular terms of the notes supplements,
and, to the extent inconsistent with, replaces, the descriptions of the general terms and provisions of the debt securities set forth
in the accompanying product supplement, prospectus supplement and prospectus.&nbsp;&nbsp;You should carefully consider, among other things,
the matters set forth in &ldquo;Summary Risk Factors&rdquo; in this pricing supplement and &ldquo;Risk Factors Relating to the Securities&rdquo;
in the accompanying product supplement, as the notes involve risks not associated with conventional debt securities.&nbsp;&nbsp;We urge
you to consult your investment, legal, tax, accounting and other advisers before deciding to invest in the notes.</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt; color: white"><B>Investor Suitability</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The suitability considerations identified below are not exhaustive.&nbsp;&nbsp;Whether
or not the notes are a suitable investment for you will depend on your individual circumstances, and you should reach an investment decision
only after you and your investment, legal, tax, accounting and other advisors have carefully considered the suitability of an investment
in the notes in light of your particular circumstances. You should also review &ldquo;Summary Risk Factors&rdquo; beginning on page PS-7
of this pricing supplement, &ldquo;The S&amp;P 500<SUP>&reg;</SUP> Index&rdquo; beginning on page PS-14 of this pricing supplement, &ldquo;The
Nasdaq-100 Index<SUP>&reg;</SUP>&ldquo; beginning on page PS-15 of this pricing supplement, &ldquo;The Russell 2000<SUP>&reg;</SUP> Index&ldquo;
beginning on page PS-16 of this pricing supplement, &ldquo;Risk Factors Relating to the Securities&rdquo; beginning on page EA-7 of the
accompanying product supplement, &ldquo;Equity Index Descriptions&mdash;The S&amp;P U.S. Indices&rdquo; beginning on page US-58 of the
accompanying underlying supplement, &ldquo;Equity Index Descriptions&mdash;The Nasdaq-100 Index<SUP>&reg;</SUP>&rdquo; beginning on page
US-26 of the accompanying underlying supplement and &ldquo;Equity Index Descriptions&mdash; <FONT STYLE="background-color: white">The
Russell Indices&rdquo; beginning on page US-37</FONT> of the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B></B></P>

<DIV STYLE="float: left; width: 49%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>The notes may be suitable for you if, among other considerations:</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You fully understand the risks inherent in an investment in the notes, including the risk of loss of your entire initial investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You can tolerate a loss of all or a substantial portion of your initial investment and are willing to make an investment that may
have the full downside market risk of an investment in the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You understand and accept the risks associated with each of the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You believe the closing level of each underlying is likely to be greater than or equal to its coupon barrier on each trading day during
the quarterly observation periods, and, if the closing level of any underlying is not, you can tolerate receiving few or no contingent
coupon payments over the term of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You believe the final underlying level of each underlying will be greater than or equal to its downside threshold, and, if the final
underlying level of any underlying is below its downside threshold, you can tolerate a loss of all or a substantial portion of your investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You can tolerate fluctuations in the value of the notes prior to maturity that may be similar to or exceed the downside fluctuations
in the level of the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing to accept the individual market risk of each underlying on each trading day during the quarterly observation periods
and on the final valuation date, and you understand that any decline in the level of one underlying will not be offset or mitigated by
a lesser decline or any potential increase in the levels of the other underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing to hold notes that may be called early by the issuer in its sole discretion regardless of the closing level of any
underlying, and you are otherwise willing to hold such notes to maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing to make an investment whose positive return is limited to the contingent coupon payments, regardless of the potential
appreciation of the underlyings, which could be significant.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing to invest in the notes based on the contingent coupon rate indicated on the cover page of this pricing supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing to invest in the notes based on the coupon barriers and downside thresholds indicated on the cover page of this pricing
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing and able to hold the notes to maturity, and accept that there may be little or no secondary market for the notes and
that any secondary market will depend in large part on the price, if any, at which CGMI is willing to purchase the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You do not seek guaranteed current income from your investment and are willing to forgo dividends or any other distributions paid
on the stocks included in the underlyings for the term of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing to assume the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc. for all payments under the
notes, and understand that if Citigroup Global Markets Holdings Inc. and Citigroup Inc. default on their obligations, you might not receive
any amounts due to you, including any repayment of the stated principal amount.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

</DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2.8pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2.8pt"></P>

<DIV STYLE="float: right; width: 49%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><B>The notes may <I>not</I> be suitable for you if, among
other considerations:</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2.8pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You do not fully understand the risks inherent in an investment in the notes, including the risk of loss of your entire initial investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You cannot tolerate the loss of all or a substantial portion of your initial investment, or you are not willing to make an investment
that may have the full downside market risk of an investment in the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You do not understand or are not willing to accept the risks associated with each of the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You do not believe the closing level of each underlying is likely to be greater than or equal to its coupon barrier on each trading
day during the quarterly observation periods, or you cannot tolerate receiving few or no contingent coupon payments over the term of the
notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You believe the final underlying level of at least one underlying will be less than its downside threshold, exposing you to the full
downside performance of the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You require an investment designed to guarantee a full return of the stated principal amount at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You cannot tolerate fluctuations in the value of the notes prior to maturity that may be similar to or exceed the downside fluctuations
in the level of the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are unwilling to accept the individual market risk of each underlying on each trading day during the quarterly observation periods
and on the final valuation date, or you seek an investment based on the performance of a basket composed of the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are unwilling to hold notes that may be called early by the issuer in its sole discretion regardless of the closing level of any
underlying, or you are otherwise unable or unwilling to hold such notes to maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You seek an investment that participates in the full appreciation of the underlyings and whose positive return is not limited to the
contingent coupon payments.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are unwilling to invest in the notes based on the contingent coupon rate indicated on the cover page of this pricing supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are unwilling to invest in the notes based on the coupon barriers and downside thresholds indicated on the cover page of this
pricing supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You seek an investment for which there will be an active secondary market.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You seek guaranteed current income from this investment or prefer to receive the dividends and any other distributions paid on the
stocks included in the underlyings for the term of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You prefer the lower risk of conventional fixed income investments with comparable maturities and credit ratings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are not willing to assume the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc. for all payments under
the notes, including any repayment of the stated principal amount.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

</DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 100%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<DIV STYLE="float: left; width: 49%">

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt; color: white"><B>Indicative Terms</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; width: 37%; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Issuer</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 63%; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Guarantee</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">All payments due on the notes are fully and unconditionally guaranteed by Citigroup Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Issue price</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">100% of the stated principal amount per note</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Stated principal amount per note</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$10.00 per note</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Term</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Approximately 3.25 years, unless called earlier</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Trade date<SUP>1</SUP></FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">October 1, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Settlement date<SUP>1</SUP></FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">October 3, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Final valuation date<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><SUP>[1]</SUP></FONT><SUP>, 2</SUP></FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">January 2, 2029</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Maturity date<SUP>1</SUP></FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">January 4, 2029</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Underlyings</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">S&amp;P 500<SUP>&reg;</SUP> Index (Ticker: SPX)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">Nasdaq-100 Index<SUP>&reg;</SUP> (Ticker: NDX)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">Russell 2000<SUP>&reg;</SUP> Index (Ticker: RTY)</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Issuer call feature</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">The issuer may, in its sole discretion, call the notes
in whole, but not in part, on any coupon payment date prior to the maturity date upon not less than two (2) business days&rsquo; notice
prior to such coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">If the notes are called, we will pay you on the applicable
coupon payment date a cash payment per $10.00 stated principal amount of each note equal to the stated principal amount per note plus
any contingent coupon otherwise due on such coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">After the notes are called, no further payments will
be made on the notes.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Observation period</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Each observation period will consist of each trading day from, but excluding, an observation period end date to, and including, the following observation period end date; <I>provided</I> that the first observation period will consist of each trading day from, but excluding, the trade date to, and including, the first observation period end date.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Observation period end dates<SUP>1</SUP></FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">See &ldquo;Observation Period End Dates/Coupon Payment Dates for the Offering of the Notes&rdquo; on page PS-6.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Trading day</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">For any underlying index, a scheduled trading day for that underlying index on which a market disruption event has not occurred with respect to that underlying index.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Coupon payment dates</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">See &ldquo;Observation Period End Dates/Coupon Payment Dates for the Offering of the Notes&rdquo; on page PS-6.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</DIV>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<DIV STYLE="float: right; width: 49%">

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; width: 37%; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Contingent coupon/contingent coupon rate</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 63%; padding-bottom: 2pt">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0">If the closing levels of <B>all</B> the underlyings on
each trading day during the applicable observation period are greater than or equal to their respective coupon barriers, we will make
a contingent coupon payment with respect to that observation period on the related coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0">However, if the closing level of <B>any</B> underlying
on <B>any</B> trading day during the applicable observation period is less than its coupon barrier, no contingent coupon will be payable
on the related coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0">Each contingent coupon payment will be in the amount
of $0.2375 for each $10.00 stated principal amount note (based on the per annum contingent coupon rate of 9.50%) and will be payable
with respect to each observation period in which the closing levels of <B>all</B> the underlyings on each trading day during that observation
period are greater than or equal to their respective coupon barriers.&nbsp;&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0"><B>Contingent coupon payments on the notes are not guaranteed.
We will not pay you the contingent coupon for any observation period in which the closing level of <U>any</U> underlying on <U>any</U>
trading day is less than its coupon barrier. </B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Payment at maturity (per $10.00 stated principal amount of notes)</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the notes are not called prior to maturity and the final
underlying level of the least performing underlying is greater than or equal to its downside threshold</B>, we will pay you the $10.00
stated principal amount plus any contingent coupon otherwise due on the maturity date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the notes are not called prior to maturity and the final
underlying level of the least performing underlying is less than its downside threshold, </B>we will pay you a cash payment on the maturity
date that is less than your stated principal amount and may be zero, resulting in a loss that is proportionate to the negative underlying
return of the least performing underlying, equal to:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-decoration-style: double">$10.00</FONT>
&times; (1 + underlying return of the least performing underlying)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>Accordingly, you may lose all or a substantial portion of
your stated principal amount at maturity, depending on how significantly the least performing underlying declines.</I></B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Least performing underlying</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">The underlying with the lowest underlying return.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Underlying return</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For each underlying, calculated as follows:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><U>final underlying level &ndash; initial underlying
level<BR>
</U>initial underlying level</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Downside threshold</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">For any underlying, 60.00% of its respective initial underlying level, as specified on the cover of this pricing supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Coupon barrier</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">For any underlying, 65.00% of its respective initial underlying level, as specified on the cover of this pricing supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Initial underlying level</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">For any underlying, its closing level on the trade date, as specified on the cover page of this pricing supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Final underlying level</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">For any underlying, its closing level on the final valuation date.</FONT></TD></TR>
  </TABLE>
<P STYLE="padding-top: 2pt; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><B>INVESTING IN THE NOTES INVOLVES SIGNIFICANT RISKS. YOU MAY LOSE&nbsp;A
SUBSTANTIAL PORTION OR ALL OF YOUR INITIAL INVESTMENT.&nbsp;THE CONTINGENT REPAYMENT OF THE STATED PRINCIPAL AMOUNT APPLIES ONLY IF YOU
HOLD THE NOTES TO MATURITY. ANY PAYMENT ON THE NOTES IS SUBJECT TO THE CREDITWORTHINESS OF THE ISSUER AND THE GUARANTOR. IF CITIGROUP
GLOBAL MARKETS HOLDINGS INC. AND CITIGROUP INC. WERE TO DEFAULT ON THEIR OBLIGATIONS, YOU MIGHT NOT RECEIVE ANY AMOUNTS OWED TO YOU UNDER
THE NOTES AND YOU COULD LOSE YOUR ENTIRE INVESTMENT.</B></P>

</DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 100%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<DIV STYLE="float: left; width: 49%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"></P>


<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->




<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"><SUP></SUP></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"><SUP>1</SUP> Expected. In the event that we make any
changes to the expected trade date and settlement date, the final valuation date, observation period end dates and maturity date may be
changed to ensure that the stated term of the notes remains the same.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"><SUP>2</SUP> Subject to postponement as described
under &ldquo;Description of the Securities&mdash;Consequences of a Market Disruption Event; Postponement of a Valuation Date&rdquo; in
the accompanying product supplement.</P>

</DIV>


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 100%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<DIV STYLE="float: left; width: 49%">

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt; color: white"><B>Investment Timeline</B></FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 3%; border-right: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 26%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #DEDFB3; text-align: center"><FONT STYLE="font-size: 10pt"><B>Trade date</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 68%"><FONT STYLE="font-size: 10pt">The closing level of each underlying (its respective initial underlying level) is observed and the coupon barrier and downside threshold for each underlying are determined.&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">&nbsp;<IMG SRC="image_001.jpg" ALT=""></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #DEDFB3">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Quarterly</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>(callable by the issuer in its sole discretion)</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0">If the closing levels of <B>all</B> the underlyings on each
    trading day during the applicable observation period are greater than or equal to their respective coupon barriers, we will make a contingent
    coupon payment with respect to that observation period on the related coupon payment date. However, if the closing level of <B>any</B>
    underlying on <B>any</B> trading day during the applicable observation period is less than its coupon barrier, no contingent coupon will
    be payable on the related coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">The issuer may, in its sole discretion, call the notes in
    whole, but not in part, on any coupon payment date prior to the maturity date upon not less than two (2) business days&rsquo; notice prior
    to such coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">If the notes are called, we will pay you on the applicable
    coupon payment date a cash payment per $10.00 stated principal amount of each note equal to the stated principal amount per note plus
    any contingent coupon otherwise due on such coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0">After the notes are called, no further payments will
be made on the notes.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">&nbsp;<IMG SRC="image_001.jpg" ALT=""></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #DEDFB3; text-align: center"><FONT STYLE="font-size: 10pt"><B>Maturity date (if not previously called)</B></FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">If the notes are not called prior to maturity, the final underlying
    level of each underlying is observed on the final valuation date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the notes are not called prior to maturity and the final underlying
    level of the least performing underlying is greater than or equal to its downside threshold</B>, we will pay you the $10.00 stated principal
    amount plus any contingent coupon otherwise due on the maturity date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the notes are not called prior to maturity and the final underlying
    level of the least performing underlying is less than its downside threshold,<BR>
    </B>we will pay you a cash payment on the maturity date that is less than your stated principal amount and may be zero, resulting in a
    loss that is proportionate to the negative underlying return of the least performing underlying, equal to:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-decoration-style: double">$10.00</FONT>
    &times; (1 + underlying return of the least<BR>
    performing underlying)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0"><B><I>Accordingly, you may lose all or a substantial portion
of your stated principal amount at maturity, depending on how significantly the least performing underlying declines. </I></B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

</DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 100%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; color: white; margin: 0pt 0; background-color: #788D41">Observation
Period End Dates/Coupon Payment Dates for the Offering of the Notes</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 52%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Observation Period End Dates</B></FONT></TD>
    <TD STYLE="width: 48%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Coupon Payment Dates</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">January 2, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">January 6, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">April 1, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">April 6, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">July 1, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">July 6, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">October 1, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">October 5, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">January 4, 2027</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">January 6, 2027</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">April 1, 2027</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">April 5, 2027</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">July 1, 2027</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">July 6, 2027</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">October 1, 2027</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">October 5, 2027</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">January 3, 2028</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">January 5, 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">April 3, 2028</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">April 5, 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">July 3, 2028</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">July 6, 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">October 2, 2028</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">October 4, 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">January 2, 2029</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">January 4, 2029</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt">
</FONT><FONT STYLE="font-size: 10pt; color: white"><B>Summary Risk Factors</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">An investment in the notes is significantly riskier than an investment
in conventional debt securities.&nbsp;&nbsp;The notes are subject to all of the risks associated with an investment in our conventional
debt securities (guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default on our obligations under the
notes, and are also subject to risks associated with each underlying.&nbsp;&nbsp;Accordingly, the notes are suitable only for investors
who are capable of understanding the complexities and risks of the notes.&nbsp;&nbsp;You should consult your own financial, tax and legal
advisers as to the risks of an investment in the notes and the suitability of the notes in light of your particular circumstances.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following is a summary of certain key risk factors for investors
in the notes.&nbsp;&nbsp;You should read this summary together with the more detailed description of risks relating to an investment in
the notes contained in the section &ldquo;Risk Factors Relating to the Securities&rdquo; beginning on page EA-7 in the accompanying product
supplement.&nbsp;&nbsp;You should also carefully read the risk factors included in the accompanying prospectus supplement and in the documents
incorporated by reference in the accompanying prospectus, including Citigroup Inc.&rsquo;s most recent Annual Report on Form 10-K and
any subsequent Quarterly Reports on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>You may lose some or all of your investment </B>&mdash; The notes differ from ordinary debt securities in that we will not necessarily
repay the full stated principal amount of your notes at maturity.&nbsp;&nbsp;If the notes are not called prior to maturity and the final
underlying level of the least performing underlying is less than its downside threshold, you will lose 1% of the stated principal amount
of the notes for every 1% by which the final underlying level of the least performing underlying is less than its initial underlying level.&nbsp;&nbsp;There
is no minimum payment at maturity on the notes, and you may lose up to all of your investment in the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>You will not receive any contingent coupon payment for any quarter in which the closing level of any underlying on any trading
day during the related observation period is less than its coupon barrier</B> &mdash; A contingent coupon payment will be made on a coupon
payment date if and only if the closing levels of all the underlyings on each trading day during the applicable observation period are
greater than or equal to their respective coupon barriers. If the closing level of any underlying on any trading day during an observation
period is less than its coupon barrier, you will not receive any contingent coupon payment on the related coupon payment date. If the
closing level of any underlying is below its coupon barrier on at least one trading day during each quarterly observation period, you
will not receive any contingent coupon payments over the term of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The notes are subject to the risks of each of the underlyings and will be negatively affected if any underlying performs poorly,
even if the other underlyings perform well </B>&mdash; You are subject to risks associated with each of the underlyings. If any underlying
performs poorly, you will be negatively affected, even if the other underlyings perform well. The notes are not linked to a basket composed
of the underlyings, where the better performance of one could ameliorate the poor performance of the others. Instead, you are subject
to the full risks of each individual underlying. Furthermore, the risk that you will not receive the contingent coupon and that you will
lose some or all of your initial investment in the notes is greater if you invest in the notes as opposed to notes that are linked to
the performance of a single underlying if their terms are otherwise substantially similar.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>You will not benefit in any way from the performance of the better performing underlyings </B>&mdash; The payment at maturity depends
solely on the performance of the least performing underlying, and you will not benefit in any way from the performance of the better performing
underlyings.&nbsp;&nbsp;The notes may underperform a similar investment in all of the underlyings or a similar alternative investment
linked to a basket composed of the underlyings, since in either such case the performance of the better performing underlyings would be
blended with the performance of the least performing underlying, resulting in a better return than the return of the least performing
underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>You will be subject to risks relating to the relationship between the underlyings</B> &mdash; It is preferable from your perspective
for the underlyings to be correlated with each other, in the sense that they tend to increase or decrease at similar times and by similar
magnitudes.&nbsp;&nbsp;By investing in the notes, you assume the risk that the underlyings will not exhibit this relationship.&nbsp;&nbsp;The
less correlated the underlyings, the more likely it is that either one of the underlyings will perform poorly over the term of the notes.
All that is necessary for the notes to perform poorly is for one of the underlyings to perform poorly; the performance of the better performing
underlyings are not relevant to your return on the notes.&nbsp;&nbsp;It is impossible to predict what the relationship between the underlyings
will be over the term of the notes.&nbsp;&nbsp;<B>The S&amp;P 500<SUP>&reg; </SUP>Index represents large capitalization stocks in the
United States, the Nasdaq-100 Index<SUP>&reg;</SUP> represents 100 of the largest non-financial companies listed on the Nasdaq Stock Market
and the Russell 2000<SUP>&reg; </SUP>Index represents small capitalization stocks in the United States.&nbsp;&nbsp;Accordingly, the underlyings
represent markets that differ in significant ways and, therefore, may not be correlated with each other.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Higher contingent coupon rates are associated with greater risk</B> &mdash; The notes offer contingent coupon payments at an annualized
rate that, if all are paid, would produce a yield that is generally higher than the yield on our conventional debt securities of the same
maturity. This higher potential yield is associated with greater levels of expected risk as of the trade date for the notes, including
the risks that you may not receive a contingent coupon payment on one or more, or any, coupon payment dates, the notes will not be called
and the amount you receive at maturity may be significantly less than the stated principal amount of your notes and may be zero. The volatility
of and the correlation between the underlyings are important factors affecting these risks. Greater expected volatility of, and lower
expected correlation between, the underlyings as of the trade date may result in a higher contingent coupon rate, but would also represent
a greater expected likelihood as of the trade date that (i) the closing level of at least one underlying will be less than its coupon
barrier on at least one trading day during one or more observation periods, such that you will not receive one or more, or any, contingent
coupon payments during the term of the notes and that (ii) the closing level of the least performing underlying will be less than the
applicable downside threshold on the final valuation date, such that you will not be repaid the stated principal amount of your notes
at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>You may not be adequately compensated for assuming the downside risk of the least performing underlying</B> &mdash; The potential
contingent coupon payments on the notes are the compensation you receive for assuming the downside risk of the least performing underlying,
as well as all the other risks of the notes. That compensation is effectively &ldquo;at risk&rdquo; and may, therefore, be less than you
currently anticipate. First, the actual yield you realize on the notes could be lower than you anticipate because the coupon is &ldquo;contingent&rdquo;
and you may not receive a contingent coupon payment on one or more, or any, of the coupon payment dates. Second, the contingent coupon
payments are the compensation you receive not only for the downside risk of the least performing underlying, but also for all of the other
risks of the notes, including the risk that the notes may be called prior to maturity, interest rate risk and our and Citigroup Inc.&rsquo;s
credit risk. If those other risks increase or are otherwise greater than you currently anticipate, the contingent coupon payments may
turn out to be inadequate to compensate you for all the risks of the notes, including the downside risk of the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>We may call the notes in our sole discretion, which will limit your ability to receive the contingent coupon payments</B> &mdash;
We may call the notes on any coupon payment date prior to the maturity date upon not less than two (2) business days&rsquo; notice. In
the event that we call the notes, you will receive the stated principal amount of your notes and any contingent coupon otherwise due on
such coupon payment date.&nbsp;&nbsp;Thus, the term of the notes may be limited to as short as approximately three months.&nbsp;&nbsp;If
we call the notes prior to maturity, you will not receive any additional contingent coupon payments.&nbsp;&nbsp;It is more likely that
we will call the notes in our sole discretion prior to maturity to the extent that the expected coupon payable on the notes is greater
than the coupon that would be payable on other instruments issued by us of comparable maturity, terms and credit rating trading in the
market. The greater likelihood of us calling the notes in that environment increases the risk that you will not be able to reinvest the
proceeds from the called notes in an another investment that provides a similar yield with a similar level of risk.&nbsp;&nbsp;We are
less likely to call the notes prior to maturity when the expected contingent coupon payable on the notes is less than the coupon that
would be payable on other comparable instruments issued by us, which includes when the level of any of the underlyings is less than its
coupon barrier. Therefore, the notes are more likely to remain outstanding when the expected contingent coupon payable on the notes is
less than what would be payable on other comparable instruments and when your risk of not receiving a contingent coupon is relatively
higher.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The notes offer downside exposure to the least performing underlying, but no upside exposure to any underlying</B> &mdash; You
will not participate in any appreciation in the level of the underlyings over the term of the notes. Consequently, your return on the
notes will be limited to the contingent coupon payments you receive, if any, and may be significantly less than the return on the underlyings
over the term of the notes. In addition, you will not receive any dividends or other distributions or have any other rights with respect
to the underlyings or the stocks included in the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The payment at maturity depends on the closing level of the least performing underlying on a single day</B> &mdash; If the closing
level of the least performing underlying on the final valuation date is less than its downside threshold, you will not receive the full
stated principal amount of your notes at maturity, even if the closing level of the least performing underlying is greater than its downside
threshold on other dates during the term of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Investing in the notes is not equivalent to investing in any underlying or the stocks that constitute any underlying</B> &mdash;
You will not have voting rights, rights to receive any dividends or other distributions or any other rights with respect to any of the
stocks that constitute the underlyings.&nbsp;&nbsp;It is important to understand that, for purposes of measuring the performance of the
underlyings, the levels used will not reflect the receipt or reinvestment of dividends or distributions on the stocks that constitute
any underlying.&nbsp;&nbsp;Dividend or distribution yield on the stocks that constitute the underlyings would be expected to represent
a significant portion of the overall return on a direct investment in the stocks that constitute the underlyings, but will not be reflected
in the performance of any underlying as measured for purposes of the notes (except to the extent that dividends and distributions reduce
the levels of the underlyings).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The notes are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc. </B>&mdash; Any payment on
the notes will be made by Citigroup Global Markets Holdings Inc. and is guaranteed by Citigroup Inc., and therefore is subject to the
credit risk of both Citigroup Global Markets Holdings Inc. and Citigroup Inc. If we default on our obligations under the notes and Citigroup
Inc. defaults on its guarantee obligations, you may not receive any payments that become due under the notes.&nbsp;&nbsp;As a result,
the value of the notes prior to maturity will be affected by changes in the market&rsquo;s view of our and Citigroup Inc.&rsquo;s creditworthiness.&nbsp;&nbsp;Any
decline, or anticipated decline, in either of our or Citigroup Inc.&rsquo;s credit ratings or increase, or anticipated increase, in the
credit spreads charged by the market for taking either of our or Citigroup Inc.&rsquo;s credit risk is likely to adversely affect the
value of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The notes will not be listed on any securities exchange and you may not be able to sell them prior to maturity</B> &mdash; The
notes will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the notes.&nbsp;&nbsp;CGMI
currently intends to make a secondary market in relation to the notes and to provide an indicative bid price for the notes on a daily
basis. Any indicative bid price for the notes provided by CGMI will be determined in CGMI&rsquo;s sole discretion, taking into account
prevailing market conditions and other relevant factors, and will not be a representation by CGMI that the notes can be sold at that price,
or at all.&nbsp;&nbsp;CGMI may suspend or terminate making a market and providing indicative bid prices without notice, at any time and
for any reason. If CGMI suspends or terminates making a market, there may be no secondary market at all for the notes because it is likely
that CGMI will be the only broker-dealer that is willing to buy your notes prior to maturity.&nbsp;&nbsp;Accordingly, an investor must
be prepared to hold the notes until maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The probability that any underlying will fall below its coupon barrier on any trading day during any observation period or the
least performing underlying will fall below its downside threshold on the final valuation date will depend in part on the volatility of,
and correlation between, the underlyings </B>&mdash; &ldquo;Volatility&rdquo; refers to the frequency and magnitude of changes in the
level of the underlyings.&nbsp;&nbsp;&ldquo;Correlation&rdquo; refers to the extent to which the underlyings tend to increase or decrease
at similar times and by similar magnitudes.&nbsp;&nbsp;In general, the greater the volatility of the underlyings, and the lower the correlation
between the underlyings, the greater the probability that at least one of the underlyings will experience a large decline over the term
of the notes and fall below its</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">respective coupon barrier on one, or more,
trading days during one, or more, observation periods and/or below its downside threshold on the final valuation date.&nbsp;&nbsp;The
underlyings have historically experienced significant volatility, and as discussed above, the underlyings represent markets that differ
in significant ways and therefore may not be correlated.&nbsp;&nbsp;As a result, there is a significant risk that at least one of the
underlyings will fall below its coupon barrier on one or more trading days, such that you will not receive one or more contingent coupon
payments, and that at least one of the underlyings will fall below its downside threshold on the final valuation date, such that you will
incur a significant loss on your investment in the notes.&nbsp;&nbsp;The terms of the notes are set, in part, based on expectations about
the volatility of, and correlation between, the underlyings as of the trade date.&nbsp;&nbsp;If expectations about the volatility of,
and correlation between, the underlyings change over the term of the notes, the value of the notes may be adversely affected, and if the
actual volatility of the underlyings prove to be greater than initially expected, or if the actual correlation between the underlyings
proves to be lower than initially expected, the notes may prove to be riskier than expected on the trade date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-size: 10pt"><B>The estimated value of the notes on the trade date, based on CGMI&rsquo;s proprietary pricing models
and our internal funding rate, will be less than the issue price</B></FONT> &mdash; <FONT STYLE="font-size: 10pt">The difference is attributable
to certain costs associated with selling, structuring and hedging the notes that are included in the issue price.&nbsp;&nbsp;These costs
include (i) the underwriting discount paid in connection with the offering of the notes, (ii) hedging and other costs incurred by us and
our affiliates in connection with the offering of the notes and (iii) the expected profit (which may be more or less than actual profit)
to CGMI or other of our affiliates in connection with hedging our obligations under the notes.&nbsp;&nbsp;These costs adversely affect
the economic terms of the notes because, if they were lower, the economic terms of the notes would be more favorable to you.&nbsp;&nbsp;The
economic terms of the notes are also likely to be adversely affected by the use of our internal funding rate, rather than our secondary
market rate, to price the notes.&nbsp;&nbsp;See &ldquo;The estimated value of the notes would be lower if it were calculated based on
our secondary market rate&rdquo; below.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The estimated value of the notes was determined for us by our affiliate using proprietary pricing models </B>&mdash; CGMI derived
the estimated value disclosed on the cover page of this pricing supplement from its proprietary pricing models.&nbsp;&nbsp;In doing so,
it may have made discretionary judgments about the inputs to its models, such as the volatility of and correlation between the underlyings,
dividend yields on the stocks that constitute the underlyings and interest rates. CGMI&rsquo;s views on these inputs may differ from your
or others&rsquo; views, and as an underwriter in this offering, CGMI&rsquo;s interests may conflict with yours.&nbsp;&nbsp;Both the models
and the inputs to the models may prove to be wrong and therefore not an accurate reflection of the value of the notes.&nbsp;&nbsp;Moreover,
the estimated value of the notes set forth on the cover page of this pricing supplement may differ from the value that we or our affiliates
may determine for the notes for other purposes, including for accounting purposes.&nbsp;&nbsp;You should not invest in the notes because
of the estimated value of the notes.&nbsp;&nbsp;Instead, you should be willing to hold the notes to maturity irrespective of the initial
estimated value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The estimated value of the notes would be lower if it were calculated based on our secondary market rate </B>&mdash; The estimated
value of the notes included in this pricing supplement is calculated based on our internal funding rate, which is the rate at which we
are willing to borrow funds through the issuance of the notes.&nbsp;&nbsp;Our internal funding rate is generally lower than our secondary
market rate, which is the rate that CGMI will use in determining the value of the notes for purposes of any purchases of the notes from
you in the secondary market.&nbsp;&nbsp;If the estimated value included in this pricing supplement were based on our secondary market
rate, rather than our internal funding rate, it would likely be lower.&nbsp;&nbsp;We determine our internal funding rate based on factors
such as the costs associated with the notes, which are generally higher than the costs associated with conventional debt securities, and
our liquidity needs and preferences.&nbsp;&nbsp;Our internal funding rate is not the same as the contingent coupon rate that is payable
on the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">Because there is not an active market for
traded instruments referencing our outstanding debt obligations, CGMI determines our secondary market rate based on the market price of
traded instruments referencing the debt obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the
notes, but subject to adjustments that CGMI makes in its sole discretion.&nbsp;&nbsp;As a result, our secondary market rate is not a market-determined
measure of our creditworthiness, but rather reflects the market&rsquo;s perception of our parent company&rsquo;s creditworthiness as adjusted
for discretionary factors such as CGMI&rsquo;s preferences with respect to purchasing the notes prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The estimated value of the notes is not an indication of the price, if any, at which CGMI or any other person may be willing to
buy the notes from you in the secondary market</B> &mdash; Any such secondary market price will fluctuate over the term of the notes based
on the market and other factors described in the next risk factor.&nbsp;&nbsp;Moreover, unlike the estimated value included in this pricing
supplement, any value of the notes determined for purposes of a secondary market transaction will be based on our secondary market rate,
which will likely result in a lower value for the notes than if our internal funding rate were used.&nbsp;&nbsp;In addition, any secondary
market price for the notes will be reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount of the
notes to be purchased in the secondary market transaction, and the expected cost of unwinding related hedging transactions.&nbsp;&nbsp;As
a result, it is likely that any secondary market price for the notes will be less than the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The value of the notes prior to maturity will fluctuate based on many unpredictable factors </B>&mdash; As described under &ldquo;Valuation
of the Notes&rdquo; below, the payout on the notes could be replicated by a hypothetical package of financial instruments consisting of
a fixed-income bond and one or more derivative instruments.&nbsp;&nbsp;As a result, the factors that influence the values of fixed-income
bonds and derivative instruments will also influence the terms of the notes at issuance and the value of the notes prior to maturity.&nbsp;&nbsp;Accordingly,
the value of your notes prior to maturity will fluctuate based on the level and volatility of the underlyings and a number of other factors,
including the price and volatility of the stocks that constitute the underlyings, the correlation between the underlyings, dividend yields
on the stocks that constitute the underlyings, interest rates generally, the time remaining to maturity and our and Citigroup Inc.&rsquo;s
creditworthiness, as reflected in our secondary market rate.&nbsp;&nbsp;Changes in the levels of the underlyings may not result in a comparable
change in the value of your notes.&nbsp;&nbsp;You should understand that the value of your notes at any time prior to maturity may be
significantly less than the issue price.&nbsp;&nbsp;The stated payout from the issuer only applies if you hold the notes to maturity or
earlier issuer call, as applicable.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The Russell 2000<SUP>&reg; </SUP>Index is subject to risks associated with small capitalization
stocks </B>&mdash; The stocks that constitute the Russell 2000<SUP>&reg;</SUP> Index are issued by companies with relatively small market
capitalization.<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;</FONT>The stock prices of smaller companies may be
more volatile than the stock prices of large capitalization companies.<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;</FONT>These
companies tend to be less well-established than large market capitalization companies.<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;</FONT>Small
capitalization companies may be less able to withstand adverse economic, market, trade and competitive conditions relative to larger companies.<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;</FONT>Small
capitalization companies are less likely to pay dividends on their stocks, and the presence of a dividend payment could be a factor that
limits downward stock price pressure under adverse market conditions.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The Nasdaq-100 Index<SUP>&reg;</SUP> is subject to risks associated with the stocks of foreign companies</B> &mdash; Some of the
stocks that constitute the Nasdaq-100 Index<SUP>&reg;</SUP> are issued by foreign companies.&nbsp;&nbsp;Investments in securities of foreign
companies involve risks associated with those countries, including risks of governmental intervention and cross-shareholdings in companies
in certain countries.&nbsp;&nbsp;The prices of securities issued by foreign companies may be affected by political, economic, financial
and social factors in those countries, or global regions, including changes in government, economic and fiscal policies and currency exchange
laws.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Immediately following issuance, any secondary market bid price provided by CGMI, and the value that will be indicated on any brokerage
account statements prepared by CGMI or its affiliates, will reflect a temporary upward adjustment</B> &mdash; The amount of this temporary
upward adjustment will decline to zero over the temporary adjustment period.&nbsp;&nbsp;See &ldquo;Valuation of the Notes&rdquo; in this
pricing supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Our offering of the notes is not a recommendation of any underlying </B>&mdash; The fact that we are offering the notes does not
mean that we believe that investing in an instrument linked to the least performing of the underlyings is likely to achieve favorable
returns. In fact, as we are part of a global financial institution, our affiliates may have positions (including short positions) in the
stocks that constitute the underlyings or in instruments related to the underlyings or such stocks, and may publish research or express
opinions, that in each case are inconsistent with an investment linked to the underlyings. These and other activities of our affiliates
may affect the levels of the underlyings in a way that has a negative impact on your interests as a holder of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Our affiliates, or UBS or its affiliates, may publish research, express opinions or provide recommendations that are inconsistent
with investing in or holding the notes</B> &mdash; Any such research, opinions or recommendations could affect the closing levels of the
underlyings and the value of the notes.&nbsp;&nbsp;Our affiliates, and UBS and its affiliates, publish research from time to time on financial
markets and other matters that may influence the value of the notes, or express opinions or provide recommendations that may be inconsistent
with purchasing or holding the notes.&nbsp;&nbsp;Any research, opinions or recommendations expressed by our affiliates or by UBS or its
affiliates may not be consistent with each other and may be modified from time to time without notice.&nbsp;&nbsp;These and other activities
of our affiliates or UBS or its affiliates may adversely affect the levels of the underlyings and may have a negative impact on your interests
as a holder of the notes.&nbsp;&nbsp;Investors should make their own independent investigation of the merits of investing in the notes
and the underlyings to which the notes are linked.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Trading and other transactions by our affiliates, or by UBS or its affiliates, in the equity and equity derivative markets may
impair the value of the notes </B>&mdash; We expect to hedge our exposure under the notes through CGMI or other of our affiliates, who
will likely enter into equity and/or equity derivative transactions, such as over-the-counter options or exchange-traded instruments,
relating to the underlyings or the stocks included in the underlyings and may adjust such positions during the term of the notes.&nbsp;&nbsp;It
is possible that our affiliates could receive substantial returns from these hedging activities while the value of the notes declines.&nbsp;&nbsp;Our
affiliates and UBS and its affiliates may also engage in trading in instruments linked to the underlyings on a regular basis as part of
their respective general broker-dealer and other businesses, for proprietary accounts, for other accounts under management or to facilitate
transactions for customers, including block transactions.&nbsp;&nbsp;Such trading and hedging activities may affect the levels of the
underlyings and reduce the return on your investment in the notes.&nbsp;&nbsp;Our affiliates or UBS or its affiliates may also issue or
underwrite other securities or financial or derivative instruments with returns linked or related to the underlyings.&nbsp;&nbsp;By introducing
competing products into the marketplace in this manner, our affiliates or UBS or its affiliates could adversely affect the value of the
notes.&nbsp;&nbsp;Any of the foregoing activities described in this paragraph may reflect trading strategies that differ from, or are
in direct opposition to, investors&rsquo; trading and investment strategies relating to the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Our affiliates, or UBS or its affiliates, may have economic interests that are adverse to yours as a result of their respective
business activities </B>&mdash; Our affiliates or UBS or its affiliates may currently or from time to time engage in business with the
issuers of the stocks that constitute the underlyings, including extending loans to, making equity investments in or providing advisory
services to such issuers. In the course of this business, our affiliates or UBS or its affiliates may acquire non-public information about
those issuers, which they will not disclose to you. Moreover, if any of our affiliates or UBS or any of its affiliates is or becomes a
creditor of any such issuer, they may exercise any remedies against that issuer that are available to them without regard to your interests.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The calculation agent, which is an affiliate of ours, will make important determinations with respect to the notes </B>&mdash;
If certain events occur, such as market disruption events or the discontinuance of an underlying, CGMI, as calculation agent, will be
required to make discretionary judgments that could significantly affect the payments on the notes. Such judgments could include, among
other things:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>determining whether a market disruption event has occurred with respect to an underlying;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>if a market disruption event occurs on the final valuation date with respect to an underlying, determining whether to postpone the
final valuation date;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>determining the levels of the underlyings if the levels of the underlyings are not otherwise available or a market disruption event
has occurred; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>selecting a successor underlying or performing an alternative calculation of the level of an underlying if an underlying is discontinued
or materially modified (see &ldquo;Description of the Securities&mdash;Certain Additional Terms for Securities Linked to an Underlying
Index&mdash;Discontinuance or Material Modification of an Underlying Index&rdquo; in the accompanying product supplement).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">In making these judgments, the calculation agent&rsquo;s
interests as an affiliate of ours could be adverse to your interests as a holder of the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Adjustments to any underlying may affect the value of your notes</B> &mdash; S&amp;P Dow Jones Indices LLC, as publisher of the
S&amp;P 500<SUP>&reg;</SUP> Index, Nasdaq, Inc., as publisher of the Nasdaq-100 Index, or <FONT STYLE="background-color: white">FTSE Russell,
as publisher of the Russell 2000<SUP>&reg;</SUP> Index,</FONT> may add, delete or substitute the stocks that constitute any underlying
or make other methodological changes that could affect the level of any underlying. S&amp;P Dow Jones Indices LLC, Nasdaq, Inc. or FTSE
Russell may discontinue or suspend calculation or publication of any underlying at any time without regard to your interests as holders
of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The U.S. federal tax consequences of an investment in the notes are unclear </B>&mdash; There is no direct legal authority regarding
the proper U.S. federal tax treatment of the notes, and we do not plan to request a ruling from the Internal Revenue Service (the &ldquo;IRS&rdquo;).&nbsp;&nbsp;Consequently,
significant aspects of the tax treatment of the notes are uncertain, and the IRS or a court might not agree with the treatment of the
notes as described in &ldquo;United States Federal Tax Considerations&rdquo; below.&nbsp;&nbsp;If the IRS were successful in asserting
an alternative treatment of the notes, the tax consequences of the ownership and disposition of the notes might be materially and adversely
affected.&nbsp;&nbsp;Moreover, future legislation, Treasury regulations or IRS guidance could adversely affect the U.S. federal tax treatment
of the notes, possibly retroactively.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">Non-U.S. investors should note that persons
having withholding responsibility in respect of the notes may withhold on any coupon payment paid to a non-U.S. investor, generally at
a rate of 30%.&nbsp;&nbsp;To the extent that we have withholding responsibility in respect of the notes, we intend to so withhold.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">You should read carefully the discussion
under &ldquo;United States Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying
product supplement and &ldquo;United States Federal Tax Considerations&rdquo; in this pricing supplement.&nbsp;&nbsp;You should also consult
your tax adviser regarding the U.S. federal tax consequences of an investment in the notes, as well as tax consequences arising under
the laws of any state, local or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #00D581; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>
</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt">
<FONT STYLE="background-color: yellow">
</FONT></FONT><FONT STYLE="font-size: 10pt; color: white"><B>Hypothetical Examples </B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Hypothetical terms only. Actual terms may vary.
See the cover page for actual offering terms.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below illustrate the hypothetical payment upon an issuer
call or at maturity for a $10.00 stated principal amount note with the following assumptions* (the actual terms of the notes are listed
on the cover page of this pricing supplement; amounts may have been rounded for ease of reference):</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Stated Principal Amount: $10</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Term: Approximately 3.25 years, unless called earlier</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Hypothetical Initial Underlying Levels: For each Underlying, 100.00</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Contingent Coupon Rate: 9.50% per annum (or 2.375% per quarter)</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Quarterly Contingent Coupon Payment: $0.2375 per quarter per note</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Observation Periods / Observation Period End Dates: Quarterly, as set forth on page PS-6 of this pricing supplement</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Issuer Call: Quarterly</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Hypothetical Coupon Barriers: For each Underlying, 65.00 (which, with respect to each Underlying, is 65% of its hypothetical initial
underlying level)</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Hypothetical Downside Thresholds: For each Underlying, 60.00 (which, with respect to each Underlying, is 60% of its hypothetical initial
underlying level)</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>*<FONT STYLE="background-color: white">The examples below are based
on the above hypothetical values and do not reflect the actual initial underlying levels, coupon barriers or downside thresholds of the
underlyings. For the actual initial underlying level, coupon barrier and downside threshold of each underlying, see the cover page of
this pricing supplement. We have used these hypothetical values, rather than the actual values, to simplify the calculations and aid understanding
of how the securities work. However, you should understand that any actual payments on the securities will be calculated based on the
actual initial underlying level, coupon barrier and downside threshold of each underlying, and not on the hypothetical values indicated
above.&nbsp;&nbsp;</FONT></I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 1 &mdash; The notes are called on the first coupon payment
date.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Date</B></FONT></TD>
    <TD COLSPAN="3" STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Lowest Closing Level During Applicable Observation Period</B></FONT></TD>
    <TD ROWSPAN="2" STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Payment (per note)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>S&amp;P 500<SUP>&reg;</SUP> Index</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Nasdaq-100 Index<SUP>&reg;</SUP></B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Russell 2000<SUP>&reg;</SUP> Index</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; width: 14%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">First Observation Period</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 20%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">80.00 (<B>at or above</B> coupon barrier)</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 20%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">90.00 (<B>at or above</B> coupon barrier) </FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 20%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">85.00 (<B>at or above</B> coupon barrier)</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 26%; padding-bottom: 2pt">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$10.2375 (principal amount plus contingent
coupon); notes are called</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: right; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; text-align: right; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; text-align: right; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; text-align: right; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Total Payment:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$10.2375 (2.375% total return)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Since the notes are called by us in our sole discretion on the coupon
payment date related to the first observation period and the closing level of each underlying on each trading day during the first observation
period was greater than its coupon barrier, we will pay you a total of $10.2375 per note (equal to the stated principal amount plus the
contingent coupon) on that coupon payment date, representing a total return of 2.375% on the notes over the approximately three months
the notes were outstanding before they were called by us in our sole discretion. You will not receive any further payments on the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 2 &mdash; The notes are NOT called and the final underlying
level of the least performing underlying is above its downside threshold. </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Date</B></FONT></TD>
    <TD COLSPAN="3" STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Lowest Closing Level During Applicable Observation Period and Final Underlying Level on the Final Valuation Date</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Payment (per note)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>S&amp;P 500<SUP>&reg;</SUP> Index</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Nasdaq-100 Index<SUP>&reg;</SUP></B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Russell 2000<SUP>&reg;</SUP> Index</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; width: 14%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">First Observation Period</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 20%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">85.00 (<B>at or above</B> coupon barrier)</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 20%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">75.00 (<B>at or above</B> coupon barrier) </FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 20%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">110.00 (<B>at or above</B> coupon barrier)</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 26%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$0.2375 (contingent coupon); notes are not called </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Second through Twelfth Observation Periods</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Various (<B>at or above</B> coupon barrier)</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Various (<B>at or above</B> coupon barrier)</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Various (<B>all below</B> coupon barrier)</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$0; notes are not called</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Final Observation Period</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">80.00 (<B>at or above</B> coupon barrier)</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">60.00 (<B>below</B> coupon barrier)</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">85.00 (<B>at or above</B> coupon barrier)</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$0; notes are not callable</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; width: 14%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Final Valuation Date</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 20%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">80.00 (<B>at or above</B> downside threshold)</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 20%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">65.00 (<B>at or above</B> downside threshold)*</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 20%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">88.00 (<B>at or above</B> downside threshold)</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 26%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$10.00 (principal amount)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: right; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; text-align: right; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; text-align: right; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; text-align: right; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Total Payment:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$10.2375 (2.375% total return)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* Denotes least performing underlying</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Since the closing level of each underlying on each trading day during
the first observation period was greater than its coupon barrier and the notes are not called by us on the related coupon payment date,
we will pay you the applicable contingent coupon of $0.2375 per note on the first coupon payment date.&nbsp;&nbsp;However, because the
closing level of at least one underlying was below its coupon barrier on at least one trading day during the second through twelfth observation
periods, you will not receive any contingent coupons on any of the related coupon payment dates.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Because the closing level of at least one underlying was below its coupon
barrier on at least one trading day during the final observation period, you will not receive any contingent coupon on the maturity date.
However, because the final underlying level of the least performing underlying is greater than its downside threshold, we will pay you
$10 per note (equal to the stated principal amount) on the maturity date.&nbsp;&nbsp;When added to the contingent coupon payment of $0.2375
received in respect of the first observation period, you would have been paid a total of $10.2375 per note, representing a total return
of 2.375% on the notes over the 3.25-year term of the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 3 &mdash; The notes are NOT called and the final underlying
level of the least performing underlying is below its downside threshold.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Date</B></FONT></TD>
    <TD COLSPAN="3" STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Lowest Closing Level During Applicable Observation Period and Final Underlying Level on the Final Valuation Date</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Payment (per note)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>S&amp;P 500<SUP>&reg;</SUP> Index</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Nasdaq-100 Index<SUP>&reg;</SUP></B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Russell 2000<SUP>&reg;</SUP> Index</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; width: 14%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">First through Twelfth Observation Periods</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 20%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Various (<B>all below</B> coupon barrier)</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 20%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Various (<B>all below </B>coupon barrier)</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 20%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Various (<B>all below </B>coupon barrier)</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 26%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$0; notes are not called</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Final Observation Period</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">75.00 (<B>at or above</B> coupon barrier)</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">90.00 (<B>at or above</B> coupon barrier)</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">30.00 (<B>below</B> coupon barrier)</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$0; notes are not callable</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Final Valuation Date</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">75.00 (<B>at or above</B> downside threshold)</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">90.00 (<B>at or above</B> downside threshold)</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">30.00 (<B>below</B> downside threshold)*</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$10.00 &times; [1 + underlying return of the
least performing underlying] =</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$10.00 &times; [1 + -70.00%] =</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$10.00 &times; 0.30 =</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$3.00</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: right; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; text-align: right; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; text-align: right; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; text-align: right; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Total Payment:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$3.00 (-70.00% total return)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* Denotes least performing underlying</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Since the closing level of at least one underlying was below its coupon
barrier on at least one trading day during each observation period, no contingent coupon is paid on any coupon payment date during the
term of the notes.&nbsp;&nbsp;On the final valuation date, the least performing underlying closes below its downside threshold. Therefore,
at maturity, investors are exposed to the downside performance of the least performing underlying and you will receive $3.00 per note,
which reflects the percentage decrease of the least performing underlying from the trade date to the final valuation date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; color: white; margin: 0pt 0; background-color: #788D41">The
S&amp;P 500<SUP>&reg;</SUP> Index</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white; color: #222222">The S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index
consists of the common stocks of 500 issuers selected to provide a performance benchmark for the large capitalization segment of the U.S.
equity markets. It is calculated and maintained by S&amp;P Dow Jones Indices LLC. The S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index is reported
by Bloomberg L.P. under the ticker symbol &ldquo;SPX.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white; color: #222222">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white; color: #222222">&ldquo;Standard &amp; Poor&rsquo;s,&rdquo;
&ldquo;S&amp;P&rdquo; and &ldquo;S&amp;P 500<SUP>&reg;</SUP>&rdquo; are trademarks of Standard &amp; Poor&rsquo;s Financial Services LLC
and have been licensed for use by Citigroup Inc. and its affiliates. For more information, see &ldquo;Equity Index Descriptions&mdash;The
S&amp;P U.S. Indices&mdash;License Agreement&rdquo; in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white; color: #222222">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white; color: #222222">Please refer to the section
&ldquo;Equity Index Descriptions&mdash;The S&amp;P U.S. Indices&rdquo; in the accompanying underlying supplement for important disclosures
regarding the S&amp;P 500<SUP>&reg;</SUP>&nbsp;Index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white; color: #222222">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>The graph below illustrates the performance of the S&amp;P 500<SUP>&reg;</SUP>
Index from January 2, 2015 to September 29, 2025.&nbsp;&nbsp;The closing level of the S&amp;P 500<SUP>&reg;</SUP> Index on September 29,
2025 was 6,661.21. We obtained the closing levels of the S&amp;P 500<SUP>&reg;</SUP> Index from Bloomberg, and we have not participated
in the preparation of or verified such information.&nbsp;&nbsp;The historical closing levels of the S&amp;P 500<SUP>&reg;</SUP> Index
should not be taken as an indication of future performance and no assurance can be given as to the final underlying level or any future
closing level of the S&amp;P 500<SUP>&reg;</SUP> Index. We cannot give you assurance that the performance of the S&amp;P 500<SUP>&reg;</SUP>
Index will result in a positive return on your initial investment and you could lose a significant portion or all of the stated principal
amount at maturity.</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_005.gif" ALT="" STYLE="height: 315px; width: 577px"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; color: white; margin: 0pt 0; background-color: #788D41">The
Nasdaq-100 Index<SUP>&reg;</SUP></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Nasdaq-100 Index<SUP>&reg;</SUP> is a modified market capitalization-weighted
index of stocks of the 100 largest non-financial companies listed on The Nasdaq Stock Market.&nbsp;&nbsp;All stocks included in the Nasdaq-100
Index<SUP>&reg;</SUP> are traded on a major U.S. exchange.&nbsp;&nbsp;The Nasdaq-100 Index<SUP>&reg; </SUP>was developed by The Nasdaq
Stock Market, Inc. and is calculated, maintained and published by The Nasdaq, Inc.&nbsp;&nbsp;The Nasdaq-100 Index<SUP>&reg;</SUP> is
reported by Bloomberg L.P. under the ticker symbol &ldquo;NDX.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&ldquo;Nasdaq-100 Index<SUP>&reg;</SUP>&rdquo; is a trademark of The
Nasdaq, Inc. and has been licensed for use by Citigroup Inc. and its affiliates.&nbsp;&nbsp;For more information, see &ldquo;Equity Index
Descriptions&mdash;The Nasdaq-100 Index<SUP>&reg;</SUP>&mdash;License Agreement&rdquo; in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Please refer to the section &ldquo;Equity Index Descriptions&mdash;The
Nasdaq-100 Index<SUP>&reg;</SUP>&rdquo; in the accompanying underlying supplement for important disclosures regarding the Nasdaq-100 Index<SUP>&reg;</SUP>,
including information concerning its composition and calculation and certain risks that are associated with an investment linked to the
Nasdaq-100 Index<SUP>&reg;</SUP>.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>The graph below illustrates the performance of the Nasdaq-100
Index<SUP>&reg;</SUP> from January 2, 2015 to September 29, 2025.&nbsp;&nbsp;The closing level of the Nasdaq-100 Index<SUP>&reg;</SUP>
on September 29, 2025 was 24,611.35. We obtained the closing levels of the Nasdaq-100 Index<SUP>&reg;</SUP> from Bloomberg, and we have
not participated in the preparation of or verified such information.&nbsp;&nbsp;The historical closing levels of the Nasdaq-100 Index<SUP>&reg;</SUP>
should not be taken as an indication of future performance and no assurance can be given as to the final underlying level or any future
closing level of the Nasdaq-100 Index<SUP>&reg;</SUP>. We cannot give you assurance that the performance of the Nasdaq-100 Index<SUP>&reg;</SUP>
will result in a positive return on your initial investment and you could lose a significant portion or all of the stated principal amount
at maturity.</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_006.gif" ALT="" STYLE="height: 315px; width: 577px"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; color: white; margin: 0pt 0; background-color: #788D41">The
Russell 2000<SUP>&reg;</SUP> Index</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">The Russell 2000<SUP>&reg;</SUP>
Index is designed to track the performance of the small capitalization segment of the U.S. equity market.&nbsp;&nbsp;All stocks included
in the Russell 2000<SUP>&reg;</SUP> Index are traded on a major U.S. exchange.&nbsp;&nbsp;It is calculated and maintained by FTSE Russell,
a subsidiary of London Stock Exchange Group.&nbsp;&nbsp;The Russell 2000<SUP>&reg;</SUP> Index is reported by Bloomberg L.P. under the
ticker symbol &ldquo;RTY.&rdquo;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">&ldquo;Russell 2000<SUP>&reg;</SUP>
Index&rdquo; is a trademark of FTSE Russell and has been licensed for use by Citigroup Inc. and its affiliates.&nbsp;&nbsp;For more information,
see &ldquo;Equity Index Descriptions&mdash;The Russell Indices&mdash;Disclaimers&rdquo; in the accompanying underlying supplement.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Please refer to the section &ldquo;Equity
Index Descriptions&mdash;The Russell Indices&rdquo; in the accompanying underlying supplement for important disclosures regarding the
Russell 2000<SUP>&reg;</SUP> Index.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B><I>The graph below illustrates
the performance of the Russell 2000<SUP>&reg;</SUP> Index from January 2, 2015 to September 29, 2025.&nbsp;&nbsp;The closing level of
the Russell 2000<SUP>&reg;</SUP> Index on September 29, 2025 was 2,435.247.&nbsp;&nbsp;We obtained the closing levels of the Russell 2000<SUP>&reg;</SUP>
Index from Bloomberg, and we have not participated in the preparation of or verified such information.&nbsp;&nbsp;Currently, whereas the
sponsor of the Russell 2000<SUP>&reg;</SUP> Index publishes the official closing level of the Russell 2000<SUP>&reg;</SUP> Index to six
decimal places, Bloomberg reports the closing level to three decimal places. As a result, the closing level of the Russell 2000<SUP>&reg;</SUP>
Index reported by Bloomberg may be lower or higher than the official closing level of the Russell 2000<SUP>&reg;</SUP> Index published
by the sponsor of the Russell 2000<SUP>&reg;</SUP> Index.&nbsp;&nbsp;The historical closing levels of the Russell 2000<SUP>&reg;</SUP>
Index should not be taken as an indication of future performance and no assurance can be given as to the final underlying level or any
future closing level of the Russell 2000<SUP>&reg;</SUP> Index. We cannot give you assurance that the performance of the Russell 2000<SUP>&reg;</SUP>
Index will result in a positive return on your initial investment and you could lose a significant portion or all of the stated principal
amount at maturity.</I></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_007.gif" ALT="" STYLE="height: 315px; width: 577px"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; font-size: 10pt; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Correlation of the Underlyings</FONT></B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following graph sets forth the historical performances of the S&amp;P
500<SUP>&reg;</SUP> Index, the Nasdaq-100 Index<SUP>&reg;</SUP> and the Russell 2000<SUP>&reg;</SUP> Index from January 2, 2015 through
September 29, 2025, based on the daily closing levels of the underlyings.&nbsp;&nbsp;For comparison purposes, each underlying has been
normalized to have a closing level of 100.00 on January 2, 2015 by dividing the closing level of that underlying on each day by the closing
level of that underlying on January 2, 2015 and multiplying by 100.00.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We obtained the closing levels used to determine the normalized closing
levels set forth below from Bloomberg, without independent verification. Historical performance of the underlyings should not be taken
as an indication of future performance. Future performance of the underlyings may differ significantly from historical performance, and
no assurance can be given as to the closing levels of the underlyings during the term of the notes, including on any trading day during
an observation period.&nbsp;&nbsp;Moreover, any historical correlation between the underlyings is not indicative of the degree of correlation
between the underlyings, if any, over the term of the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_008.gif" ALT="" STYLE="height: 315px; width: 577px"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>PAST PERFORMANCE AND CORRELATION BETWEEN THE
UNDERLYINGS IS NOT INDICATIVE OF FUTURE PERFORMANCE OR CORRELATION</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Correlation is a measure of the extent to which two underlyings tend
to increase or decrease at similar times and by similar magnitudes over a given time period.&nbsp;&nbsp;The closer the relationship of
the returns of a pair of underlyings over a given period, the more correlated those underlyings are.&nbsp;&nbsp;Conversely, the less closely
related the returns of a pair of underlyings, the less correlated those underlyings are.&nbsp;&nbsp;Two underlyings may also be inversely
correlated, which means that they tend to move in opposite directions from one another.&nbsp;&nbsp;The graph above illustrates the historical
performance of each underlying relative to the other over the time period shown and provides an indication of how close the performance
of each underlying has historically been to the other underlyings.&nbsp;&nbsp;However, the graph does not provide a precise measure of
correlation and there may be relevant aspects of the historical correlation between the underlyings that cannot be discerned from the
graph.&nbsp;&nbsp;Furthermore, regardless of the degree of correlation between the underlyings in the past, past correlation is not indicative
of future correlation, and it is possible that the underlyings will exhibit significantly lower correlation in the future than they did
in the past.&nbsp;&nbsp;We cannot predict the relationship between the underlyings over the term of the notes. For additional information,
see &ldquo;Summary Risk Factors&mdash;You will be subject to risks relating to the relationship between the underlyings.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The lower (or more negative) the correlation between the underlyings,
the less likely it is that the underlyings will move in the same direction at the same time and, therefore, the greater the potential
for one of the underlyings to close below its coupon barrier or downside threshold on any trading day during an observation period or
the final valuation date, respectively.&nbsp;&nbsp;This is because the less correlated the underlyings are, the greater the likelihood
that at least one of the underlyings will decrease in value. However, even if the underlyings have a higher correlation, one or more of
the underlyings might close below its coupon barrier or downside threshold on any trading day during an observation period or the final
valuation date, respectively, as all of the underlyings may decrease in value together.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The terms of the notes are set, in part, based on expectations about
the correlation between the underlyings as of the trade date.&nbsp;&nbsp;If expectations about the correlation between the underlyings
change over the term of the notes, the value of the notes may be adversely affected, and if the actual correlation between the underlyings
proves to be lower than initially expected, the notes may prove to be riskier than expected on the trade date.&nbsp;&nbsp;The correlation
referenced in setting the terms of the notes is calculated using CGMI&rsquo;s proprietary derivative-pricing model and is not derived
from the returns of the underlyings over the period set forth in the graph above.&nbsp;&nbsp;In addition, factors and inputs other than
correlation impact how the terms of the notes are set and the performance of the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-size: 10pt; color: white"><B>United States Federal Tax Considerations</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You should read carefully the discussion under &ldquo;United States
Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement and
&ldquo;Summary Risk Factors&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Due to the lack of any controlling legal authority, there is substantial
uncertainty regarding the U.S. federal tax consequences of an investment in the notes.&nbsp;&nbsp;In connection with any information reporting
requirements we may have in respect of the notes under applicable law, we intend (in the absence of an administrative determination or
judicial ruling to the contrary) to treat the notes for U.S. federal income tax purposes as prepaid forward contracts with associated
coupon payments that will be treated as gross income to you at the time received or accrued in accordance with your regular method of
tax accounting.&nbsp;&nbsp;In the opinion of our counsel, Davis Polk &amp; Wardwell LLP, this treatment of the notes is reasonable under
current law; however, our counsel has advised us that it is unable to conclude affirmatively that this treatment is more likely than not
to be upheld, and that alternative treatments are possible.&nbsp;&nbsp;Moreover, our counsel&rsquo;s opinion is based on market conditions
as of the date of this preliminary pricing supplement and is subject to confirmation on the pricing date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Assuming this treatment of the notes is respected and subject to the
discussion in &ldquo;United States Federal Tax Considerations&rdquo; in the accompanying product supplement, the following U.S. federal
income tax consequences should result under current law:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Any coupon payments on the notes should be taxable as ordinary income to you at the time received or accrued in accordance with your
regular method of accounting for U.S. federal income tax purposes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Upon a sale or exchange of a note (including retirement at maturity), you should recognize capital gain or loss equal to the difference
between the amount realized and your tax basis in the note.&nbsp;&nbsp;For this purpose, the amount realized does not include any coupon
paid on retirement and may not include sale proceeds attributable to an accrued coupon, which may be treated as a coupon payment.&nbsp;&nbsp;Such
gain or loss should be long-term capital gain or loss if you held the note for more than one year.&nbsp;&nbsp;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We do not plan to request a ruling from the IRS regarding the treatment
of the notes. An alternative characterization of the notes could materially and adversely affect the tax consequences of ownership and
disposition of the notes, including the timing and character of income recognized. In addition, the U.S. Treasury Department and the IRS
have requested comments on various issues regarding the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo; and
similar financial instruments and have indicated that such transactions may be the subject of future regulations or other guidance. Furthermore,
members of Congress have proposed legislative changes to the tax treatment of derivative contracts. Any legislation, Treasury regulations
or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences of an investment
in the notes, possibly with retroactive effect. You should consult your tax adviser regarding possible alternative tax treatments of the
notes and potential changes in applicable law.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Withholding Tax on Non-U.S. Holders. </B>Because significant aspects
of the tax treatment of the notes are uncertain, persons having withholding responsibility in respect of the notes may withhold on any
coupon payment paid to Non-U.S. Holders (as defined in the accompanying product supplement), generally at a rate of 30%. To the extent
that we have (or an affiliate of ours has) withholding responsibility in respect of the notes, we intend to so withhold.&nbsp;&nbsp;In
order to claim an exemption from, or a reduction in, the 30% withholding, you may need to comply with certification requirements to establish
that you are not a U.S. person and are eligible for such an exemption or reduction under an applicable tax treaty. You should consult
your tax adviser regarding the tax treatment of the notes, including the possibility of obtaining a refund of any amounts withheld and
the certification requirement described above.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">As discussed under &ldquo;United States Federal Tax Considerations&mdash;Tax
Consequences to Non-U.S. Holders&rdquo; in the accompanying product supplement, Section 871(m) of the Code and Treasury regulations promulgated
thereunder (&ldquo;Section 871(m)&rdquo;) generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S.
Holders with respect to certain financial instruments linked to U.S. equities (&ldquo;U.S. Underlying Equities&rdquo;) or indices that
include U.S. Underlying Equities.&nbsp;&nbsp;Section 871(m) generally applies to instruments that substantially replicate the economic
performance of one or more U.S. Underlying Equities, as determined based on tests set forth in the applicable Treasury regulations.&nbsp;&nbsp;However,
the regulations, as modified by an IRS notice, exempt financial instruments issued prior to January 1, 2027 that do not have a &ldquo;delta&rdquo;
of one.&nbsp;&nbsp;Based on the terms of the notes and representations provided by us as of the date of this preliminary pricing supplement,
our counsel is of the opinion that the notes should not be treated as transactions that have a &ldquo;delta&rdquo; of one within the meaning
of the regulations with respect to any U.S. Underlying Equity and, therefore, should not be subject to withholding tax under Section 871(m).&nbsp;&nbsp;However,
the final determination regarding the treatment of the notes under Section 871(m) will be made as of the pricing date for the notes, and
it is possible that the notes will be subject to withholding tax under Section 871(m) based on the circumstances as of that date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">A determination that the notes are not subject to Section 871(m) is
not binding on the IRS, and the IRS may disagree with this treatment.&nbsp;&nbsp;Moreover, Section 871(m) is complex and its application
may depend on your particular circumstances, including your other transactions.&nbsp;&nbsp;You should consult your tax adviser regarding
the potential application of Section 871(m) to the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We will not be required to pay any additional amounts with respect to
amounts withheld.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should read the section entitled &ldquo;United States Federal
Tax Considerations&rdquo; in the accompanying product supplement.&nbsp;&nbsp;The preceding discussion, when read in combination with that
section, constitutes the full opinion of Davis Polk &amp; Wardwell LLP regarding the material U.S. federal tax consequences of owning
and disposing of the notes.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should also consult your tax adviser regarding all aspects of
the U.S. federal income and estate tax consequences of an investment in the notes and any tax consequences arising under the laws of any
state, local or non-U.S. taxing jurisdiction.&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-size: 10pt; color: white"><B>Supplemental Plan of Distribution</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI, an affiliate of Citigroup Global Markets Holdings Inc. and the
lead agent for the sale of the notes, will receive an underwriting discount of $0.10 for any note sold in this offering.&nbsp;&nbsp;UBS,
as agent for sales of the notes, expects to purchase from CGMI, and CGMI expects to sell to UBS, all of the notes sold in this offering
for $9.90 per note.&nbsp;&nbsp;UBS proposes to offer the notes to the public at a price of $10.00 per note.&nbsp;&nbsp;UBS will receive
an underwriting discount of $0.10 for each note it sells to the public.&nbsp;&nbsp;The underwriting discount will be received by UBS and
its financial advisors collectively. If all of the notes are not sold at the initial offering price, CGMI may change the public offering
price and other selling terms.&nbsp;&nbsp;For the avoidance of doubt, the underwriting discount will not be rebated if the notes are called
by the issuer prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">See &ldquo;Plan of Distribution; Conflicts of Interest&rdquo; in the
accompanying product supplement and &ldquo;Plan of Distribution&rdquo; in each of the accompanying prospectus supplement and prospectus
for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: #788D41; color: white"><B>Valuation
of the Notes</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI calculated the estimated value of the notes set forth on the cover
page of this pricing supplement based on proprietary pricing models.&nbsp;&nbsp;CGMI&rsquo;s proprietary pricing models generated an estimated
value for the notes by estimating the value of a hypothetical package of financial instruments that would replicate the payout on the
notes, which consists of a fixed-income bond (the &ldquo;<B>bond component</B>&rdquo;) and one or more derivative instruments underlying
the economic terms of the notes (the &ldquo;<B>derivative component</B>&rdquo;).&nbsp;&nbsp;CGMI calculated the estimated value of the
bond component using a discount rate based on our internal funding rate.&nbsp;&nbsp;CGMI calculated the estimated value of the derivative
component based on a proprietary derivative-pricing model, which generated a theoretical price for the instruments that constitute the
derivative component based on various inputs, including the factors described under &ldquo;Summary Risk Factors&mdash;The value of the
notes prior to maturity will fluctuate based on many unpredictable factors&rdquo; in this pricing supplement, but not including our or
Citigroup Inc.&rsquo;s creditworthiness.&nbsp;&nbsp;These inputs may be market-observable or may be based on assumptions made by CGMI
in its discretionary judgment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The estimated value of the notes is a function of the terms of the notes
and the inputs to CGMI&rsquo;s proprietary pricing models. As of the date of this preliminary pricing supplement, it is uncertain what
the estimated value of the notes will be on the trade date because it is uncertain what the values of the inputs to CGMI&rsquo;s proprietary
pricing models will be on the trade date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">During a temporary adjustment period immediately following issuance
of the notes, the price, if any, at which CGMI would be willing to buy the notes from investors, and the value that will be indicated
for the notes on any account statements prepared by CGMI or its affiliates (which value CGMI may also publish through one or more financial
information vendors), will reflect a temporary upward adjustment from the price or value that would otherwise be determined.&nbsp;&nbsp;This
temporary upward adjustment represents a portion of the hedging profit expected to be realized by CGMI or its affiliates over the term
of the notes.&nbsp;&nbsp;The amount of this temporary upward adjustment will decline to zero over the temporary adjustment period.&nbsp;&nbsp;CGMI
currently expects that the temporary adjustment period will be approximately four months, but the actual length of the temporary adjustment
period may be shortened due to various factors, such as the volume of secondary market purchases of the notes and other factors that cannot
be predicted.&nbsp;&nbsp;However, CGMI is not obligated to buy the notes from investors at any time.&nbsp;&nbsp;See &ldquo;Summary Risk
Factors&mdash;The notes will not be listed on any securities exchange and you may not be able to sell them prior to maturity.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>&copy;</SUP> 2025 Citigroup Global Markets Inc.&nbsp;&nbsp;All
rights reserved.&nbsp;&nbsp;Citi and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are
used and registered throughout the world.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->




























<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"><SUP></SUP></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  2  H# 2(  A$! Q$!_\0
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##__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_005.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.gif
M1TE&.#=A00([ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M1/^6$8UNS0L8%/K'.JSA#(&D0QK,8 =!JF$-$/TC'L"P1X@<*,,N!F@;!W+
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MQI?DT0U$L<,>5B3'=\91C#>5HQN3@QL7G<M?XG1#&Y<XT /@X#HF_",< P"
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M)]M%QI"Q#A4E'Y")# D& $/P#TT@'Q,@!&6 !T>S"/]P#_1[>89Q"FG' !@
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M @?2" E!#\_DMB A#:DL'PR :@6!XZYS )],&QR$#[@P"M >[6+.OZ;.$O.
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M[%^V9]JL_:NFJAZL?^=JR2,(%GW^F649;Y02QI6"9$%&/ <?A#!"":\JY0$
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M5X '63@'8^ %"0.&;=B'56@&;/@%>3B%6>R[1)1)KKF'<3D?HB@(E62_&1
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MJ?B&&NH+U72*8"T+!< #^ 2 &E TMB ",0, !6##D8"'9Y!#!EBS2=B#BGB
M*##-BG4GF;*&)R""(] ")  "+W"'D1"'7Z40D%6^<! C )C1IL &6I ""HBZ
MLG"!IE@$%HF^*9A70% ;8)@(AXC:DR ']P, 8#@&MB  +S+:++Q8@D"&-U@#
M,@@#-(@#.3@D9"Q#7* (*7 *=LB"4]$!6K4!5)!<7,P(>1 %2 & !-B!1R@"
MMK"!(ZF$LE#-69@M3(B]DH '*@( 4?B'SJ,("KB\O#W:O2V(]F$'A5HFJZ4]
M> @._X<8 'LX!E,P!5&()8UX!^'MA6M(K++0@"4X!7 P![:X!4FPA:+3B%+
MD8I8 / 9 _'K2X2EB$D0++0T"7 (*VF(AK %@$>07;TE"78(A1&XCTV@ M9%
M1$7LA(KH 4^8&YPDB"&@",RMB"LBB&)0FP(% !/ 26!8/XK@ 85PPXH(@86H
MAE: !%O@A5QX6ZC +6)@ [;0LO9])YDBAA_0 OE@ABW @GXUW!J,A;#M ,Q-
M@$@HB'!8!F&(@_"+10Q @!V0A'7:IU/9 NXSAZRM"!+0"RS[A C6VM?0 H<(
M!1:@" NPA5$H61$>8=K-!0X0.8+8!!+0/R L0W' S/]Q /]CZ 9GZ-*^@()\
M"&-: )D@6(AO$,V*& /3;(<0<(B><HU( H/U\P0L=M^1<(86X(-NR =AJ((H
MP-T6[K]/" $2F"\+.!4I8( '<*!83,-=" EG<"$5\@***  '6( %2+2,P 0)
M<(!.> U[!( F\!LZ$&0_+ E92($?.($94((NN]\-7 =73IY(8HO<*XLH\"8B
M*%Z-4(=/H%6VH-A;* ,Y#%ARN%'R_0=^6(9W,$>KR .'H(1CY8!/H(99GDO:
MW4Q&. 1=**G<W<!N8*^*&()V<(/H<XBU.( SR(0U2"N1Z-Z^>$#>H @^L(0)
MZ68 ( -+20)RIF7H"4D:F]J"Y:?_(*@K2JB(*ZCCLH "4Z@&:PX)5[+/F7W!
M'2EH G"@A%;H+*:?AK8O4S@"',"!J%.!YJ06AU  &A;FL@CAI;"&Q!/:)I!D
MZ0, Y2'HLMB#DT9IJMB';.@%RFJ'7IB%5H".>,B%=[WF5Z"&7V6&HRG@64 S
ME88M8=@%_V0+%R"_?U@'2HX Z0*"BH@!**B!*#C=I=B&6OB&;X@%74">LO@!
M9.#H\"AHBF@#HYY=JKB'4["&4_ %RCN&05B&;:@'<J"%;" $9F@'61 %7:!'
M;<"%;$@$?IB'6I"&1(!'KWZM,SB5"K#(@G . ,"(^@2 8,C)JP@#MC 4'OGK
M*!3L<G*\_Y$HAPY2#8( A51@AJ'(!M"@!UF8AJ3I!ULHWE(@$6!(AF' B&KH
M#H)@!5[^.W, !EV8-8KP !G(!(\M"%#XA6% +F@(ADW@,,,PCHI8 Q:>D*"M
M"$[.;6>*S:K(!U8HWE98A5Z A7PX!689!U\@!E4@B$"8ED X"FKH!52 "7QH
M3G4X!%"(!WVP\ O'\ S7\ WG\ [W\ \'\1 7<0U'!WKP!WB@9G3PA4$0AE&8
M!5%8WBG6@DL(!F8@!W78\'$XAW.H!T@]!WC8<708\1"/ATQ0(P;XA7D8\B5?
M\GH Z-T1<B:7\BFG\BJW\BO'\BS7\BV_<'Q !3ZD"G 0!?_]AO]9  :E@ =2
M6 8=&829& 2%BH9L.(48Y1WT:015P 9MT/,]Y_,^]_,_!_1 %_1!)_1"-W0^
M'UA[T 9F<(1.*(-; YDG4(:6PH>I//1+OW1L, 8,H(@2<(8\Q_10-_1NZ(*R
M0 5G$/545_559_56=_57A_587_5CD(5&E@IUV :VNH:?X#EW8-UCZ(5YX(]\
M2 7-,H4P 85B@ :B\89YW3*JAJUZ0 ,LT.-,EAT=B 0,W!$$!H!AY1JWK AI
MJ&]GZ@5??(IP:'1>B 5NF89BT 7CN@=V0 5&((2= (9!2(2ZT@9SX =;8(14
MZ =PT 5&\ 4P)VU!X@=SV(F"R =S" 3_*M#ALKB!%RB+%MCF"8F'"Z"('>B:
M6B";"7 $\1[W3MIMD>B'A$>'U6"&HBL'=+"9?D"'W#QQ=4.N>ZB'8I$'=#C=
M@P>D?("!"$" .Z #;U ''SC6_RF%1*"( ?"#?/R:<)BU$Z"%KO$' G"("AAY
M9RIYN#7GI^!Y*)H%C6^8#V0+*PB$M08 '*B&>T"#$K@#D?>:+7 (-/":>A 5
M UCGK%^EK8^0KW>B?%@!>@8 %5CX6; &E/R'H@V<0'"("^T:>-A5O-=[5N)[
M"/'[$.J&:U@#2G:('2"QBH@"LHB ^Q@A67"((_B:#P8 R9]\5:I\=BXG>)!<
M.>B!#0A;#1@>_QE0 2\@BQJP!F*(A T5(7IH!6^0*AY9 S7-^]8/I-?OY6<Z
M@O\9 X(8!P#QAC.01N]+! MA?>9O_J[GD<M_'7I0A#0L"P^XXU_$!P%8_>7W
M?BAR?B;27<&!!VI0A%@@A&L S4)<"&'X&+8 B#FC1N'[9_ @PH0*%S)LZ/ A
MQ(@2)U)TR*X#  #0*G+LZ/$CR) B1Y(LR=$4.9,J%982MO)EPUY-8F2L"6!"
MC!M1;.W[U\(F #][:L$L:O1H146:?*E#ZO0IU*A25:*<^K&E0G$+_5&+A<Y@
MSW_"1J6SNFT T+093P@!ZL(JW+ARY]*M:U=NU;L/L1JL%J</E4;J!O^'BE/%
MP , !-+$41%D$P, *T1-@_5NX>"4@\-)9#=XG,%VLN*0?I'6P 2U-HND<:GW
M->S8LF?3AIFWML%8S0PZ V'3 '#5:A^@?<+Y8+L_P"\0 :[FW;M[[!B"NW8)
M^ 92^GZFG2!GS:-\GH0#L+,.-_KTZM>SCWL[9+JR",7Q0\BOW4%RQP_*JV^0
M'3_](%3+'9IH@@5Y"0)U@3L(%:(6 Q=<@,,Y"XDC! ,%_*8:)0@IXT$!"IR!
M@TTZM'<BBBFJN.)#[WG4#S*X($+-0>_@0@@NTJ$RR"#G 3,)(MH<-(XMA)32
M#CB[$!)*2@9IHB"40$F!4"\+))B+0H?@D!C_E![ DY YQ>RFCBY.9)0)BVFJ
MN2:;>KG8$3S/]"./)DW]DTTR_^3BS32@B.5*/JS\@PXM6OWSBC'_Q*(---G\
M$XPI!QFBH (\=)%"#K6D4H(/"JBVQ3_R- ,/"@K^D ]"XU@9I0W#0+1*%R[(
MTB:MM=IZ:TEO?L0.+:#]0TL]_QPSBS4NC;,*-+,8-,D]!A%2UC7 S-+-/_C@
M\M\F0+T0# 49N3 ',2GM<]D_[9CC20Y))!&&)(QDY$,B*'100Y39L#-=*RRH
M%4( &=%PB@P9 ?'/O04;7+!!_1R\,,,-._PPQ!%+/#'%%5M\,<89:[PQQQU[
M_#'((8.LJT?>*'/0_R#Q_,/-*;=L\\\XOBBCBD&!D'O(E]0$PPHV_[@3BD'V
MF&$3 [Y,PXD;D"BCC3'$)*,,,=%$@\PRPDBC#=;57&."<#64 ($+7Z052C'5
M9.. 32GP4<<FRR """"L=,-&1C?@*37>>>.=##+>Z/TWX($+/CCAA1M^..*)
M*[XXXXT[_CCDD4L^.>652[X-*>2*5,PW"*FBSS_&#-/W/^K 4HR?_Y 25BF@
M;8.,-=7\8P\L_QE"@ ,F!!#$/P(>Q$X_P0LO_'_ "PB':B8@\X_*_=2BA214
M9-0#%EC05),=*B_43S$0R!#%.\.+/S[YY9M_/OKIJ[\^^^V[_S[\\<L_/__]
M]=M_/_[YZV_^*TV"U$XH!D&,8_PC/NX@A3=H88YWD"(9O#A&.U+Q#%0X:A[O
MT,8HDH&+=,R#%\*@Q30.H@M2X ,>TMB/1\*@EB-\:2%1$ X7_,<0>H #5S:\
M(0YSZ!&2460?K8"%*OPDC)-!(Q4]FQTK7)./5@ #/\U E3=080^#:",5&SF(
M+!(UDG;H02V?8(@_2*0:4NBPC&8\(QH;PL./X$-[*N&+2,+A@HP40 ,U80-#
MY*&%#Z1% 4J03QH#*<A!TFJ-KX&C2.Z0$0JH0@0:T ":&+*/- !E \$@)"8S
MJ<GV&%(OB P)/1H   <T8QSSF$>S&N**"D0F(S/_V"0L8RG+NW3R+I\,B35^
MX0^*U,,=@.A7#F8IS&$2\RBUM,LMX5(-;4RQF,Y\)C1/(L/:)#.:UKPF-NMR
MS+I4,YO>_"8X;3--VG0SG.8\)SHGLDVZE#.=[GRG.]<YEW;"LY[VQ*8\Y4+/
M>_*SG\+,9USVZ<^!$G20 %T(.[SANW^$HQ2ZH(60C*$+8 A('Z-P12H)!@Q=
M<,,@R- %C0XBT(*2M*0X/&A"UL$*-BQT&:/PASW&88Y5:(,7U]C'+I@Q"U5,
MYQ_*8,4Q%F$.=)"B&J%@!A:79]*E,M6,*$4(-9ZQB!H:!!:U, 4]_B$*E\QC
M%,Y('2..0XHO24-GSOA'_S-*$1J;@F,?;GTK7.,JU[G2M:YVO2M>\ZK7O?*U
MKW[]*V #*]C!$K:PACTL8A.KV,7F]1<M'(DDJ*K57###%?$XQ<MBI@Q4&.00
M-_O2,WK!,Y\![1_%P(0NA)&,U;*VM:Y]+6QC*]O9TK:VMKTM;G.KV]WRMK>^
M_2UP@RO<X1*WN,8]+G)K&XW,D:0?D56(-E0QNG_ 8Q??P-(_;%$.@]BB+,F0
MQK28IXN#Q.)D33TO>FUUBW&^2!"2#08!RTJ/6?0C&<,@!RKV,8U6^,X:RNA'
M*_2!C5[\ QC1$*EKTJO@!:OHJ0CIQRCD\8]O:,,<L1A$,/#SBD#@XC+>",0D
M@O_%#7K< Q>!\),X5!&(483E'R-E,(QC3!<'+X0;!/S'=@^"PGWXKAV^0V&.
M$2SC(1,9-C162'1>\N(B,[G)5&&O;);LY"E3N2-'?HJ4JZSE+:L1RK'),I?#
M'.8K.P7,8CXSE<F,%#.CN<U%5O-1V.SF.<,8SD:1,YWSC%X[%P7/>OZS2?D,
M$S\#NM #%;22$VSH10_YRO+HQ4+9<0M;6&,ZWK#%*23LC%J,PE?_$(<K0G'@
M.]G"% LE-*-3'4\O4T0?NO##0K^!"G34 AOYV$4\6)&-<HRB&=:014^C\8MX
M$ (=[I!%/7CA#2&KNMD*/G(RB#$)R8Y"Q*^XQO+4L0O_;(#U.*NH$#6D<0MJ
MV6,7!T'%,IRM[O/VPM,B>:Y!4K8R6)@BL[78;&<_^X_0CO9G!L&')6+Q#6@0
MO. &/SC"$Z[PA3.\X0Y_.,0C+O&)4[SB%K\XQC.N\8USO.,>_SC(0^YPEP(R
M),Z5+"F"A0U32&-Y\"B%,7YAD%KDV!=E\08U?E$,YHW"(.18Q"W,X8^A$[WH
M1C\ZTI.N]*4SO>E.?SK4HR[UJ5.]ZE:_.M:SKO6M<[WK7O\ZV)W>B@J-I!^-
MD"PS;G$/6'3#'*IXAS6ND8Y4\.,;KF"'./H1U73$@A[%R,4]?F'>?Z2"&.L^
MO$E%P6J*L ,6^&'&-\31BD#\_T) V0A$*7H"#434 E4C!D<I$&$-@H$B$*W
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M0RKH0RP8 U6]@SLLY$+$@SX8RD'XSC[8@P,^6,),PS\F1([9@QLAA#S@!SZ
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M, #L+0#-,CQP(,QR>^3#'?R#)Z3;/W""D!A$(MP"/Q#R/RR#(^A8&?S_@R'
MY2.,FD&TLRXX*&.B\$'X >HH@D&0PB(@!"5D S1$DB@ PD',@QK\@QAHT1W
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M$(B V A"%4;J6NK*#"Z!%<Z3*+%&%4Y![N !/F'!$)! -$<!),!A%<S/?*"
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M$Y\(Q2A*<8I4K*(5KXC%+&9Q&GM(PQ7@4)?_F@1C$%HLHQG/B,8TJM&'SP
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.RG2F-*VI36\:R(   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_006.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.gif
M1TE&.#=A00([ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M@TF@#IY'#E2033$P#HU 2;9 >L&7$>L0#*M!#K7Z)5PU&^?2#<VP+O__L Y
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M@;@C9[/PV#],41M[^&(9N2F'V?Z!C/]7_,R#'W14.S[@D@AH@%I/2!43 '"
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MP23,PC3,PT3,Q%3,Q>1+<D"%&:@!61@'NQ2A$VF#?Y"$S.,#=%C,=Y $%Y"
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MD >.. /P((!&$.1A> 4]T(- !5#_6[7;&JB"+\ !,#B%%? %255G^D.&#=B
M/ZB(<+ !\"@ )KB#39 (,7")'RB3  L4.U$'_O1E>3A%  @ KL2(@P:/$^!4
M '@ 5:V\ /V&1-B$ ?*&0ICF$1G!CA:X9' ))^CD?W@&T06 "JB(2P6 'YCJ
M)_'<$[$"@Z"Z!+ '4)T  \V(/3B1";"5 Z"&Y O0:  &:K"&8 !3B8B'2@(&
M7;BS?OB%C@T'6D &15$';& &>(VD4Y"1=?"%M\YCIQ8XF,X!Q!8(F':),:@(
M9T F#Y#@* $&6($!?,B'$XV 7_@G\- @C, '(T 8:,U1B=ZZ%; !$+ !&]A2
MB= '6B"#_WYM!EWX!4/(N6SEA688A&48AUKXA5SP!73PA5'XJA?!!UE@!D"H
MAG?(!5H0!:>)6,BV/-J: L8C!53PA>:..P#X@\";"'8X AB(@N">DF. %0:(
M 1UH. "P 'S0@A.ASXG !Y_*%H3!'<O3/3X  V<P<&=HVW](AE=@A I+*5*H
M6VRX)?#R!K$9AU#(A_#Z!U#HK5/8FFOH!65@VAU^1NZN/'_06@#(@G]8!X2!
M@:4."C?)AM=2 ''@1/ (9XD(!!,X@>V,!H09@JX6N'?<"%00@VKPAR3'0+]#
MA&)1AU4@/;;JL%#(VQ#;VW^0!1/S6Q5C,88\O(<\RJ@4\S$G\_\R-_,S1_.+
MI :U=@DK6(96N%.7*(!#^ :,!(;%2/..S 9= ('7D@54*%5&L 9D  9NP 2#
M&P!L.(:A1)@L&/0\A_1(1X:I5-:+Z 0.4($;4 $50--_"%Z'X(;;WKIZ:8=<
M^ ;E-;3F5;3::+1@@+1FG,NZQ,U9I_5:M_5;Q_5<[TMV,$T 8()[H98$6 ==
MQTUT6%*$@8!%L =R((-;ZP!G& U\L-$360)P4(<J0!@JT =BY_9NOTO=U AE
M.(5<U05=J/3N.@2@*(=CR.=_Z(9MN09:6(=W0XUP&(5W0 =[ [BC.$IW6 U[
MV$[M-/&H.P3P*, RH!8(0,-'"3FAR0#_0E$'*(, 7YF'7QC?%1(2)W )!9""
MRW6)E(5K6^V&6LB&1@ %4. %7E@G=!"$"<L$6$@9<2B&<4@%5B@$HG"%0B"$
MVE@&0QB$5N*':L@@49"%ET&%1AB$_VSJ@>^H>(X<<+!6:F(&(>^3<)@EA'D"
M>/V%A[D ?'@% 6" T<SDMPX]  CK;^"  HB!<_=F6UV%-[B$$, !'="!'-#I
M_%BJ?-A=<K 'A?#9R9L'OUJ'P*.'SE '>\BM<W"'_%QZIH\G?C AE[@#/,BR
M$PG:5)$#-$! A%Z F'4(?TA4 ^AE\/B ?^ #&B3&?0B&C@WYC-"/=X '>-B'
M>@"'=KP(?5AX_Y1H?,=_)U]HTA#8V!,A !!3E18X$2C(AP3'%/.1@&0H.U<4
M0]VS!S5(AUEP EZ <:9V;=Y_IT^88E.B;%$Y!VPT^(JHA-?R@3]U"11 [Q+4
MO4Z8@F"H@CHX @7TB+MN.8<8!PQ<"(GPP-T'B'\"!Q(L:/ @PH0*%S)LZ/ A
MQ(@2)U*L*%',!  :-W+4.$.=Q9 B!2;1F !)I8.9.FYTL,0"@ ]*-G(Y-_(F
MSIP2?85K*">.'B''E%PS*"\4.H'J9,$;>*X4(5GI_DD#9.C>OV>$ %D;2"X5
MH5SZ_KD"U,C?P&V[=+)MZ_8MW+AR_T%A:7?%N[EPVVB4D%"570!)_O]M8"E$
M+^+$"'DV=-7"AS1.6<P5=";KT[A__&ZEZ3=0FZEQVWJEFU7N&2YSJ>J)8[5/
MH#5?YWH)\S?J';!9:=<J[NW[-_#?U# $CKGQ</"1G X *&'SH+@:=M_\"]0Q
MP*;DVMDR;A@MVK]UZPQ>FS<(I#MWH.P-? 7L7[I<Q4H)%!4-ET!5W@2V F]O
M5#;;_,/.( ,%8\IV"2JX((,$^5*71A%DM!$1DFR43(,2A:,  !"TDU 1=M7Q
MCRD=.9%4ABDVI$M/#1%SR1R\H&C0(B )5 A[ JTB#7RA6#.*0(,HTXA LE0C
M4"A%Q5/+-K0,B(A _E2R"##96'DEEEEJN27_EUUZ^26888HY)IEEFGDFFFFJ
M>24P:70DPA <_5%*!!JI8LV:>:XY33!JJ%%&,EM.<\P-=A7A#",,;)1 &,OH
M^2BDD9J)3&H-<>-%%4ODP 8]!J%3XT X#M3,,?"-\LPO_+E3BT"SS".0*<_\
M8\\OWV#S3SFY"#2.+JNP4PZPP0H[++'%&GLLLLDJNRRSS3K[++312CLMM<"R
M\PM+.("#Q$8U[',*(83T\VNUY5++#CL#J5,L.^! H4$&'6FBSCLM;&3#.^2:
MNR^__3[;RX<,S6&&0,N(4%1!Z#QBXS^+8/6..?*0<LTLRZ@SBS._N#(.;<BD
M\HX^^]C3BC:P5$-/_RO&[,*C0-C8HB+,,<L<$K<;$8 !%/]LLU$?S\V,$SG^
M4-"1( )ALI$!SOR\]#_=+31(%8HT<L83:!5T3C:9P?8A-*[\HXPJP]@T#RRH
ME/-/.ZO4(L\_\T#S#S"JL%Q-+KIHK3-O3.N]=\SYT,#1 M&,]<\E5'@R.-\A
MT?- 1_C]\\U&'Z2;N(I.*\3.)3NTL(4P$-5C3%MJ43XZZ<&1 P-'$TQ5^DWG
M:')  K'G</8_HR1P0 F!L-Z@Y0O!@T^G$)US=TZB[WX\\FRUHT)'S"0?$CS4
MV#-]/0/18P\UX#V_7>\&,5-%$5M$08061L2CG?';J[^^0\DPMU$/VK _/__R
MW1=D#1QAT*'''#_E<U \DH(.:;BB10+IQR^*(9!PT (925$'-IB!N']XXQ2R
M"H\OJ$&0]-&O@_-S1QPTT@)N6.,U'CQAXNQGD-6=@S(&T0<MR) 48;3B%+*P
M43MXT8Q!+&,<M?A%+GR!#E^,8A>DT!H^9,$,0%3C';F@A2B"L1L44A%Y[?!%
MG#0"ABIRD6DJ=(HH=N"\0W3!205)QBL8,0YUP$(@M4 8-I#QCW[,PAOT&4<H
M\J&;?X#",_\XA3+^<8U>*,-YX0C%0+B!BBXR,G'9X @#.M?(26:(%@9$"#5F
M$(5 ?L,*2*@>0?*"B'&  Q"MFH9 4B''=(2"&K'_$(@@B,&*(FF/%T6QQRRP
MX35V0.D?YK@%+_HQCV$2LYC&/"8RDZG,93*SF<Y\)C2C*<UI4K.:UJQF/K"U
M$0I$0YC7_"8XPRG.<9*SG.9,)C]B8<*$E$("OAC((6QP08*<8Q'C,$?1_A&+
M]_S#%JAL1RZ^L<A_R$(;H!!(+O;S#US(RAVQ"(;SU%&@?XBC$8*XAC(RJM&-
M<K2C'OTH2$,JTI&2M*0F/2E*4ZK2E;+4H]'PAC<P^M%J,((C$) &,5JJTYWR
MM*<^_2E0@PI28]0"' MYA@C \(QZ3 ,*03!JP@[QCG'$XD.I\&,WO'8-6JSC
M9>*(13AN@XY:M @9/#H&_S+<<8I9O4P@R'@%)>,:'';4 Y0)D0%'.F!7N?(5
M.*Y8G4)JD8,5M. %3OC&0= A")! PQ"%<)(_BC&.5+"B$-5S12$((:ME&&(0
MW-!,-<J!"U'(XC6H:,0@7B40#O:UM6]I1QT$( "O(400D*R  EVK6\1\D2#/
M: 0B2-$4A$SN'_#P8SPP- Y[N+!MXAC(.JQ&#\JHPQZ3.X<[UHFWW7)7)T5X
M'QD0LH]":>0 MT@'\;JKWIST=B3ZV"M.6+O>^3[D&AS82#X+PHP*< 0',Z(O
M@$/27A7)-\ &-@A@-J*+@TQC(QW @B(.+.&)#'@BZ,A+08K[CW?X;!SD,(B&
M&?^VVKQ-N,3_N -'$%F0:?"  !HQ@(ECW) *1R0>@E#%VP3RE*A,I2I7R<I6
MNB*0KX1E+&4YRQ1E?&!LO* CGC (-CAR MHIN<H.NN1(V"&(?+RC%/@0"&A$
M0QK3H$8UK'$-;&1#&]O@9H_;M3)]G5&GCF3!(%C8R!&^#.<]T_@A^^CE+/CI
M'OC(AS[_L(_C],,?_P!(0 0R$(+VO%XBV,4$0A:(*Q*P$3E*&LXLT@DZ7M&,
M9<Q!:?_848]^%*0A%>E(_TC2/Y;4I"=%:4I5DA2N<ZWK7?.ZUUJR!BP89Q<+
ME.(8WYB''#@B!SSYNMG.?C:THUTF2C6W=>+81E6Z(1#_4ID*5:IBU3]<!2M9
MT<I6N-+5/WCE*W^QN]WN?C>\XTVL.4YH(P?@$  Z4 QV/.,*+-C(!!JA+WD3
MO. &/SC"G04PG8P#&]K0AFL@)C&*60QC&N.8,#P&,I&1S&0H4QG+_N&R3N_6
M'3A85!LT,8NA <  S^4+1WA!<CCW^2'TB$4LGMNUKX5M;&4[6]K6UK:WQ6UN
M=;M;@6<^22YP)#O_T,<%-.*!LS'=P7Y4NHQK/I'/A8[$6&<D.JAA"!?WY;G_
M($<53-**?VR!(W/X[]<GK'6)#*_K<9_D'!90@(WHX>K_>,-QSH$ZC7PA8'<O
M\=P3E/3#SP\?BF"Y1AQ@M8'H_V$C3SA'S0"P=L8C'LNM2^_9"4*\<_C,*Z(O
MR.(YOSUOA( ENBL(&S9BAG"<7",R5[V$$^^[T09R(+\P!"\^E U#".)\U1B$
M(1 [Y%@,@A2=&H8A1&'7U./^>-.0 $M08/B!N&,/&L'"*#;"B/%4W\"Z3T@Y
M5I&77>3X&;MX!S-.$8Y9Z.,:J4D%/N3!"JA2XQ?C>$4PK$,JL$,VK$(B#53Y
M48XR;$(J(,0YV M'#( 43%Y!^()&V !Y+4$"'I@EZ00YN (W9(,OL,T_#%HZ
MX$(W&)HH5(/C))1 W()_Q$* #$@^_5(PG1,.YJ .[J .P@,X@$,[R$,Q@8,[
MK,&$P/]!/N##/"R#*3#",E##$6A$!FS!(/0"/, #,N6#;=%9/?"@%WXA&(:A
M&'Y3.FG736 #+-Q"+- .JK&2JOV#D! )06D/K,F:D_"20%3410D5'_:A'_[A
M1EU#-?B4-I3"'I1!);@"1FE#/)0! G $!1Q#/_A 1Y = ?R"/]A#3GF4-AQ"
M1V3 &CP#((XB*9:B*9ZB3A$55.$$."R"0)""D+G">Z3#*&A#JOP#*=@#N,T"
M/PB$+?A'K=Q*.:C"0+S5!N9$\(S$.5 B "B #SS7.%R#"W3$!RC"+RR 72C
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M/= '.>31'H&"A?X"Z! #(7$E*QU@^2&##)@ ''Q5$&@$ EQE,5R"'- F1WS
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M"@!@@!R <KZWO%XH-SX@)?2>W?0.1/4.!/8^W?9VKT!\;_@Z=T&(0RV( SL
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M$GP2$5@!$<\A'-*!^5AJ';J&'MI!]=:AI:21'=H!\\83'\[R%I40'T@1&.*
M$A !;U9A%4B"*.8@$%9!D3PA%95!#RA!$8Y!H7:#).)A#R@!$^"(&A3!)%Q!
M)T4!+..A)'CS%H#A$R!A%-PRX0Z!2BCA$MA'.?\/86$@@1(";")Z(1$$81$Z
M@0D4(40#*A *81$BH0D4@1KR1A$8 1 6H0W^0!#H<B(:H1(, 1'.H X6(7M2
MH36R(1 H01!T\1\\@1W" 12<LADV]!\VH1_*819JTA3H46?<X!]P(<06H;,F
M0A?H1PZB<A_88$/WH!Q*(:M"X?!(XA.@81D.82)>H4 FHA_ZX!_V(.#<H+'T
M 0ZT-#GY0#1S0=W&]!^J@0U*0A<NX1_48"+:(5!)8@]"[Q$D 1#VA"2DP1*Z
M@1<@P1$0P3Y)(AKV@!A@P1(B@1%4P94281>0H1(L@1$8P8%(@N/^@1)0@QC*
M(&_.8!S2X0\F@A)F<Q3_*N$?*@$7_B$?]* D@N$3+&A/W^$,@A0:PF BBL$1
MQ.$,#LQ9?6$B(D$95@$0ADD.)N(>+F$?XF!")T(=YH!C]N$3RJ$,>/4?;F$3
M2@(8_* DF&$.NL8=S&!K] ".2"(2Z&PB+$%570,3[K,/ZH 3+ $Q(R%(D<$(
M/*$3+A82<(,DM*$(Y& 3/O9K-($)+-82,+0A+=48_N%VK.$6'&\BLH$.;!84
M_&$/$D@.X$@<:B$82D%=2>(26L,<3.$4D$$22J(4(@$;[""0BB$3X-$2AB$4
M#O8?.H$;2"(9)($;VB 6DF</-M,3D,$-!N$?],$-$K(4@H 0J&$4DH ;]'(B
M_Z1!"!P!&)@A"[@!$=%!$M8 %;Z!#"#A&+*4$8:@%KY!$^) &NB1%^XP#28B
M&B27).+@'QJA@B(A9"=B#DR'SD2A%HAF#7Q!$]JC'# !*?\&#XRA#8(B&C)A
M:\2@%@RA0=_!$")J$A9A%B#!4DBA0.-#$J#A$&:!'I:!#^AE7A.!&$*A$.CA
M&C+A)?\!&1"A'^1 &>AA%J9L(HQ!$^HA#8Z!'G2!$TJ"#C2*'(!A&.J6&_SU
M3X=A0%>572="'K:!&[;F$9(!+8=!7B?"%'@A'![A%NB!%BKU.CZA'[2!#O)A
M'SP!1R=B&!@A'!!!%.@!&7J7))SA$=@%$\SA&<C E?_FP0_B07PC 1[88+0,
M01#H01X^01EVP4XF(AW.H!I69Q/:80^X\1_>00^^X7GY@!XFX41]@0_@P4_T
M81? 92*HP0WRX4^V00ZZIA-2 5/6P1)ZH20001#,P4_2X1 :-DP@02Q3PA4T
M(1]) A@L(4Q+@AT< 154PA&DX6JD80K\[1^B@1/0PQ\ 80N"U!!TX6JR00@0
MH21(H1;<DAK:@&I)8A<*)!F@ 1U^@6GC@@SL81SJ(QS28%^;P2B0P1C.@1L4
M>70\01V, 3ZN80Y(<1]$H13ZX8)-HAQRX1;,H7)-XAL0H1I6H=Y*HAH P1F2
M >%( A;.X!C&@!W.01K(ER3_AF 8?E)M T$S)P(.4@$0!ED= &'A=.9W/($2
M_H$65N$[7:$6W@ 8T&$1P/$?M*$4)$%RN2$7LM0>>D$1 E89@+0DX $5,@$(
M^( 1<G@T?4$2B" -%(%-=AD7VN --J$6@G0B,*@/KN 30$$:^6&A3<(<_A$@
MS_DD\,$@3V(<OD$2C&$6TL 0SK(=0($5H.$3^$!AN888.($:4$&@K]$>'@$;
MDH$,'J&?_Z$8/"$-G)<6SKD<0"$-)H$:^H$6PC0:/B$-&&$?'-DD^H$3TB 1
MX $9(G.]J"$7)($/-($65G$BE*$5+H$/GM(@T\$5#,$2TF 0KEIML:$1.B$-
M$ %^_TNB',C1)*(4)? A'G=1)<KA)DFB$KB6))2!I>]A$[9&'4QAM 2A7.'Q
M%W*X%M@L+E1!JOCA$7 R'OK">"+J'&8!?N'A$<CQ%.2'932!Q036#305):9A
M$O @)=1A%::@-5)B%Y+ 3Z62&7:A#^9!@K_:EP.A05^A@DCB&I@!$;A9&$2W
MX>XI'$R!I2M1,E$!2R?"'=C+&. L94JF).YA%ZQ-'?Z1'&C!%Y;(&\*T&D!H
M-/EW(N9!:2>B' (N-$[!S>;A&K\A%EY2'S21'4Q!%^C2']1+&6(A7P9D7-LU
M%KZAA+9[F-XM+C(Z&&*!&^OA+,-A%_RENDV"'6R!%OB1'__8BQILP1[F01GJ
MP659<Q>> 1Z6P1M+8AQ.X12,MQ[,VR2& ?6(P1W<X2S!X14 2AA- AA*(7EY
MT"24H128*SR)9AF8@19^X<5/0;_,@1:8H<E?G)[ FAE<@<I;L"2@81@LQ\E9
M#!VV(1E\X1>:O!E(41J201?,_!1\(17KP16&P<R;7#@G8A^DG,Y/ 4Q(HAN6
MW,E[(1W+P16F_,5[8;!+*!D*_11Z@1FVQAZ:H1D G:#KIQF&X13:'&9)8AK6
M'--?/('$@= QO<D3G"3T@=";O,F3<RB8@<RI/!FZQF.^_,4;"QULNLQ?W!5(
M,1O6G,I_H16C(0Y"(11DH?DNER3__($-""$7YL92-W04Y@ 6!&$7T.$6DFPB
MFL$-8*$0^B89 N$^.T$3A))WV"!$D<$/<*$1<&$?G($/2N(:_  49"$45.]1
M[6,2<$$0=.$?, &;;T$.<&$0;.$<5 %XTT$.$"$7! %Y^J 5>X$. GX63&=[
M PK="P$6P.$8K!4MT9WEX&$>))5K".$3 EY  J&T_R@.YET4_ $<SJ DZF$/
M $$5!*%XU"!(;8$- AXU9@&&)R(9X@ 7"J%UA*%]=7@3'D$HKVD.B(-K%L$2
M EXLE'55_8 7B)WUCGTB6"$3I#U:%L&-22(5]D#:8P$=6B$_=H84H* 26*'M
M&Z$ATP$-_]H@%-P>3?G4"3!!%-Q^O9'A"21![UFA$33=4C*!" K![7$A(?_!
M$8J $-Q>%G[1'8B #F3![?,7&_$@#^@^\*^8)&+!"1RA[0._$L$A#]"@\@/_
M:]Z!#("@$=R^%39T&8S $@"_$4I](N*!"?8 ]1N!I?_!$*2 $=R>%48+'X3@
M##:_$7('4\$ #)(_HN@5"T2_$6YA:X[!""BA]NT<'2R!"0X_\'%AH1=!"@#!
M[47!T.QN(KP!%Z0AE/^A%[@Y6AN(##94#"(1&TY!%6IV(LB S\G'%@"BTK^!
M]\8,-+?JF"=H _]1^C70V"U?G!K^$Q1J8#5<W"8U1 >FX2EABO]\6?PC;V R
M7;)@-<26:> Z6-;(Z&NHY]E 9*]N";)HB=E 9[-Z/;((R.6_:+"P06KX+N0_
M=*6D81(Z,!>C@?%R9>-CD=;3?_APU537L,^]@<%ZX9)ED4^P@=]2H<+4D!^<
M@?I23?ND<R ]J>-0(7LT=Z"H0@.]<8S9$ RZ@;ZP,3IE<4R^@=M^@<IE,;3H
MT:1+FSZ-NJ$O4J7'15I7FALKT]<6F1X$S#0L7:7;/6)7^ITF>*6W92SMR)UI
M0,M*>W-D6IPF<J57H2JM[Y&YTN@B;2Z-2%GI: )+-\IF^A;FT=<4\1O8+@P0
MB_,.:1O(3M&2<PUCD;KYSSU?B!(6*^'_##1/%)0T9 XCZ U42@[]-!2,(>(,
MY(\=;EC43243_I/.'$E8!,HI:/WSC0[-6+3*+/0T5H4J#=6CB'C_D%.(%^\T
M](HJX QD#Q2*6(2-(.D,E$\2<EBT#"+X# 2/'VA\%(HN._X#3 ["-/2,(O8,
M!,XD3%B$SR'7#*0.(U2,TY ML&SW3SQ+&&+1,(T<^$\^0'@D&"#2\/?/+S4H
M-] XHKA"W3_9U'!,0\JX!Q\905BDRBLG%D."20V-T@J WE@!5VJBCDIJJ0"2
M-@YPI;UH6CF3K7K:J:.]<R6JJI(FJVCHE',:JZ2Y:IHZB>)J&CDGDK9KKZV^
M2IJOQ)(&S3<-_^&C:4/Y(-.0/J^$)@QL;!$3VC'Q-/1-HPV5PPR@_Z "YT#+
M1-,0,5M:]$PQ#?7#6YWMZO(>D2EQ=M^,W$"%"K/_</.AHLU91 U# W4SL$7$
M&-.0/2O6Z>LOWQ$D[4#U0&21/]*<^XJZ!_O3$#?=A&;-6NX^B-\PS*+R8YV\
M#G2*MQHM3%:^#3&S3T.T$-I0MT6#6VK22B]]+U:D#?,D:?#X/%HYZY%F#<6E
M73.-::>T.YHK.HNVCBNF;4/T:-.<2=H[O9@LVBDWCP;-R*7Y@B=IR20\6C;P
MDL9.+Z9]8V]ISV!;VB^WCM;,OZ/)0XMI]%P]&C!(CT:.X%X/*YHWB?^15K9I
MR6PL6CC5CJ:.YJ6= K=%U2!.FB^YAL;,V*&)0[5H[% N&C5:DZ8-S*,I7EH\
MV)@&.=/*+R^J-'J8U@?LHFGS!_)XF';(<:3E4E%I:]@>VA\=C^:,&J;1879I
MC[!&&CA7G(9&WJ+%,A9I9GACFAN?CR;)**6%\S[P,*8TK;"$:>XP#].H07BA
M4<9>2K..ZR$'%*4IQQ5J-9HUU*,TJ C#X/I@&CT,HWAM,,T^ E@:-+2C-*/X
MA&G:,*[2^"%BHXE&'DR3#@F2IA($*@TI.F&:-Y N-*?8@VF,(0;F*7&)%I&'
M-4(A#PS^8QEK*07?_@$.>6A1&8V0Q[$:8HW_@=!"'+D)S3ODL8M?P -N_L!6
M,>;5$'5H48N#\$;-Z/6C;;1C&Z.!1S%8X<70= ->OXAA0\X!CSFFPA7B@!LU
MQ+@/!L)''H2PQQT'(H^!:6.$%CGC' 6AC:"%!AI'XH8XL,&FT,AQ%LRX4&B2
MH8YWK$(TXIBC*7JQQM"P USS6,8R$AB:?<AC$-6X)%W&9<709%&+QNCB%P<2
MQG^,,9J=E$<L?-'(T&!#'^B8I2KG* ]#W,.8XUC9.HYA#)>%1A[.$$4@+5(,
M0G[)(N:8XS,$(8_%#>21THSD:-I!27> [1_R&-DUDF%&< KB&:*T""D/EHYM
M& Q*URC$.RT"2W6D_R(TYZBE%FV!2[B5 US\\"4P+2+,04##F.'8$C1RA\4Y
M=@.0SV2B34>ECTGP@1*!\(0A!R*+2H1C'/20E2T\@0E%+$(0AZ@&F60Q T"(
M@A1QH)-%[*$&3UQB$YK0IS'BP ]VO ,<S-*&)P*AB$,4HA*G>\<NEG &5I!B
M$0:QB#HH$09*/,(3@6D(*30A#J+*BAV/Z(0B%&$(0+!B6/7@10L4,54VX"4T
MJX"#)S0!"5.,\@SV* <Y]L&L>V@UK6O=5D,*\X0_L (6AC #Y_ZA#<L&@A*'
MF.@<A$'6?1QK'(ZPQ&$3.XC%66,.1V"%*G)QA<(U!!5_N.PGO&D142QBJ/]%
MM<@ND*I4ICH,2:*8 2%D08HS_,0B\1"#5C>1B&>2@1:Y_>(USDK:DEC$&7R
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M#Y PA#_#C=X(7:I!!K[@"I@P819Q#L P!VE "7^ @_^P"-?W#X46,MS("9_
M"?H$"(G@"KI !IH5&O4@"700"69 D0U!#48T$)O09@/!#?.H!TJ!47MP"JY0
M"9HP4>R0"WIP"6ZP"7 #!U<R#)$0&ND@"=S8"9V0*_(@![#@"J3 !D.4#H^
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M_ "B(MH0X* &PV )^7 &,)4'8\"B3R ',#H5P#"CT0E3A>+_)JO </_@";9
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M8/D/NP *\+L'XGHN]FL:L["/".('J>"_?>!] _$,!&S ]QL:]Y *2M<0^^#
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M<0\-__!C3&Z'< FWAP[28 ALX AC>AJ'X?2.5T&JP ?".!#*$ LHK_*FX0Z
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'$DL\*2  .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_007.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.gif
M1TE&.#=A00([ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M!< ,B*B02AB! @JLP-1R^9K3HO8XK4BN=@%@@WW8(Q!W=.T2,JO!&\00/77
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M4'&\UP@(&9EJ^1#^T%\#$0[L@#3B$#L#40^:1 _P0$?FP YG2#AL69F305P
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M#P<V =!E .=0#ZJ($&O7!J:)/<A"$$8L 8]LQ@K$D!"QQKS3R9X<$VV /5J
M#>X@J2P!"K8# O<P#_M0!GM0!TWDRK:#"/_0 PU@ 1[,"@ID"/3P*@S!#+6,
M/3RY$-)0D#[0:!>P .^9$&M'#ZR'3Q0@ 90L$.]0?7V'$I:,/9^@QIL,(M9\
MS2\ACFD0$\UP!VDPT0=QO0 PC3R 592L9^DC 080!(>9$*$01U"3$.(@#N__
M$&L!, @T9CL60+@$L7;GX)  D +14 R9S!(1O<X478P8C1@;"0!?D!C\(*T
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MFC#@!:[4.%X5R8 ])C#;@W$-2FD[ 0"HUX#$OO /)6T[3\ 739T^/^ )FP8
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M#J/ZH\C#?YP1'R(/X#S*F](I\D3Z RW)P (1]3=(\@@RC\+QYEX G$\T*+#
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M!.D%%OR0DW\HD2(*J( >"D*.93"##!'323LJ 08GP!$ EU##1CKP%$4VDS>
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MAW3(( (V"&QHBI,P "E%"0; +M[@AV!  >(% !WH!%1X!8C@PH;:-?$880
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M.]B%N.R'; C>?#B$5J."32.#JS7GP<$OG< I '"%;W8R9J*$1Q $>?@%B<:
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MJ</U4/6%R*OJ.':&$B!7L !@_P=-B($EUPO*50AZ0($/\ )$:#4[:,QY0,^
M_ =\J!AQV@3Q65UO&)QE3PC=K CU9/=F$J!J< $\J 9 ;0(K:.LT1XIX,!1W
M$)\N /!_B#@  ._D55X"P!AG8 1&T(S_;<B  MC*>#<(:"@X>*9X/_JA5IB!
M$MB!$P@">*KUJ-"&-+""0DN((8"(*NJQS=;I@0 '=J 'O8UW86#C&\GX/@(D
M38R$7,"51)*,)8 (P_T'K5( )K#'G%\):R ;-E7Z&V+.W;!VI/"'O<0!(&B$
M;NA. &""8_CSIS^(:_BN7 -[J.=8HFCKX"2(=^!6?LC0?9_ZHWB'F$0ABLBV
MLH\)>&@U!L""D,;[XXGZA$ '0LB@=5B%0- %3[&%0*"$G( &1! $*VZ'70@$
M56#,7B $5L"ON#^*;>"<DW#-OV>(>JB=#Z!QT5>9P#^(:0B%1" M:"BT6A"&
M?3B=87 %=Y@%_W'8AU<H(%.HEU%P!FN $5AP]('@_*/0YIXJ<=1/B'>@(.^<
M<.8'&]4WB&?(!T28FE>0X&1(A6/(MG%8A6^HV$"X7TH8MV-(!5(YAU> I;NG
M#7XH>(24_H7X9 1(ROF?_K./B=0;"$+P)&L B%JFAOT;%TL;K7__!M%3&*G=
MOV+!5"W[MR^4PFN>= G+YO$CR) B1Y(D20T-@)0J >BA5O(ES)@R9]*L:?,F
MSIPSI[%1B4F;SJ!"AQ(M:O0HTJ0?HY%JJ/ IU*A2H_+#!.XI+7;_DGEC)NS?
M/%G/3BE<U4_A*'+_H@D#5LVB+(7B=$4K9_<NWKQZ]_+M6X[:RI1D_/\2+FSX
M,.+$BA<S;NPX;YB41]X]KFSY,N;,FC=SOFP.E-JIHD?_XU?H*KUWV')M>U7O
MGBYJHZR9F\4,%S"P[Z3-HO:J73Y=S7Q=>]H+&>GDRI?_NU3'1,H,S9A3KV[]
M.O;LVK=SE\J,D:"*W<>3+V_^//KTZD6;"MU='35Q_[)I^X<LUS>%ST854YBO
ME2E7/>-/1*4\H] WH]3W5"E?K<<</S2D-( T#UIX(889:K@AAQUZ^&%Y[:&W
MSSGI-0@B5*RDA$(Z*+KX(HPQRC@CC35*)>)YZJACHH,NDG,!!B+8."2111IY
M))(RXHCDB2^*@\\YZ"0Y)9556GDEE@HM>63_DUEZ^26888HY)E1;&MDEF6FJ
MN2:;;5YH9I%HNCDGG77::2><1,IY)Y]]^OGGD7D.N2>@A1IZ**(/"FHCH8DZ
M^BBDD;+G'I<]2GHIIID6NFB-C6KZ*:BA@LDIC9Z*>BJJJ=I(ZHRFJOHJK+%F
MR*J,KLIZ*ZZY:D=KC+;J^BNPP99)Z9F6"GLLLL'R"J.OR3K[[*?+OM@LM-5:
MFZBT+E)[+;?=WIDMBMMZ.RZY:8(+HKCEJKONE>=^F"Z[\<I+I+L>PCLOOOFZ
M6&^']^K[+\ 8\LNAOP$;?'"(Q,9I+,(-.ZRHPGHR_##%%7<W\(8%6[SQQAAK
MJ#''(3OL<88@BWQR_\ D8V@RRBWCJ_*%++L\\[HP6R@SS3E[:_.#..O\<[4\
MK^<ST$4C*[1Z1!N]]*](\\@TU/DZC9[245NMZM3G57TUUZ%F;=[678N-Z=?E
MA3TVVH\B34\LL1Q2(3*QN&+./]>\THI[XK@2"S,*$1,+*OPP.'':A>N*]#2W
MI.,//?;H<DXKW:R32S7!M++C?*GL0X@]YY3"CB\]GFTXZ7XB34L@LF#SCRG(
MN9/+,J H1$DX"OG28C'$B')@/+E@M4WIP>>*RCCJ07.,,ZY@@PM!X^R"D$-.
M/?0/,:A09!%&_^#3R"S2?/,]^.&+/S[YY9M_/OKIJ[\^^^V[_S[\\<L_/__]
M]=M_/_[YZ[\__^DW4\H]+&0,6A #.>THA35^H9!=K&.! 60&,7Y1'':,0B'C
M$(0IT%&/#7*P@Q[\( A#*,(1DK"$)CPA"E.HPA6RL(4N?"$,8RC#&=*PAC:\
M(0Y+: ]9M"@]HIB&.8#!#'W(8AW=*$8Z5-&.9-B"'_Q0!S&X\8Y9V.,9H C'
M*9"CD%E,0WA>C)4H(C:><<B"$- 0'# &D8O:;0,0O""0->K1CUP,(AC_4(<K
M!D$+NBED=%_\H[G$2![,*82042&D(0WY#S\"LI&C$F2G".?(26(+DJ62)"4S
M":BRD8>1FORDD3@Y'D^"LI0U$F5W2&G*5<((E=S_424K8_DA5VX'EK*\I89H
MJ1U;XK*7$)L2+WTIS//H,CO!'"8R+V;)5F$RF<Y<U3)KU<QG4C-&Q<3.,:NI
MS>1<\SK9W"8X;Q3-7DTSG.84V#B95<YSLE,]W;3.-]NYS7=6)Y[RK"8]J6//
M>SXSG\S9)S^3Z<_E #2@PQRH<@IJ4%\B-#D*72@N&TJ:AT)4EA(=#44KRLJ+
MBB:C&C4E1Z?BT8^",J12&2E)-6G2J* TI91<*51:ZE)'PG1P,[WI<FK:QW7B
M-*4Z721/>_K1G\I4J,(C:E"-"E&D*K6IK$OGM)+J5'XR=:I"K:I5<8K5K,YT
MJUSU*53+HXU \ (>3UF'_RX"<0IU\ ,7@6C%67;ZU9O2TAVE(,<W2"&X?QRC
M&.]X!3:<D8IPR*(;-IVK2VFI#07^@Q -_,<N L@-;X"B..=8Q5-F,1W$II1X
M'1I&0OX1">E!I'K7NXA"XI$(3K"BM:YU;2P0\=K9LN(0E*#M:REQ"-RZ-A2$
MX&UK=Q$(X+*"$+P@KFV)2XG? A<1L2!N($)!7.,"-[;$985L@:M;XO*"N;P5
M[G2/"]SD:G>WS7TN< .QB_!6-[O-5:YY>=M=XH9BN.V=[FW+2USG[G>]Z97N
M=]W+6P'CEK_R]2YNZTO<71!XMH3(+V\/$=\"HS?!EG#*AIHANW^\HG;_6$6+
MLO\1#5@<"!^S4$@_NO&->>@C'R[.AS_\D8]SJ&(<\GBQBV^<#V!D@\4XSH<\
M6CR,8_CXQ^[0!S5 ,0X9_U@>_G!&+9;\8WVX(Q^@6'&+<4SE'4>CR"]VQXVY
M88H?YT,?/BX%-LALYA;30AIJGH>,4X$,,L-X'OMHA8W?G(]>R*/*378',8XA
MY2;/8[&#QK$_YJ&,6L"9S/(8QRFLX><FC^,8/<XRHN>1#2)CVL54'@<M[,%D
M+;MC'+6XAHXI?8IOI/K%9F;'+;S\XWJ, AUT=G$W4'%K%PLC%;O.AS1H<>M'
MXZ,496ZUF<=ABF( N=.?UAV,1PWC<<RC%.?01ZMQ/ O_;!SYUK:PAJQ??(T:
M9_O%\.C%/,K]XE' H],XSL8OU.UB:]Q"WOE0!I_)'&,K"R//. YR/KH!#5GO
M6Q^S /*NPTH>>K3B&=Y8ZSO L=A]D,(=[)@%/EHAC:O\@Q[[D,=HV($/^4!E
MK_V(ASZDLE=^8*,>4WEL/+0B%7"4XQ_GP,=46N1Q=^3\'^9 N53B.IIW)(?H
MI#$Z::3T#GP('2I2 @<^ AB5=Q1/'S*/BCD(- ^<3\4>\,B'E*2R= UB&"I0
MKP<Z(L8/=M@#'2"7"CGP<8VK1X4>^%#&R*?2#W8H8Q]-?XH^SG&-L-<('Q!1
MR%Z?LG7,*?(?]\!'S>\H%7@0_PCQHE$'/HHW&LJ/QNZ)ETHXF$ZD?."#CT_9
MJSFP0?BG8 X=^/#PC+ 1BUDTQ!CHX <H0M'%?W"#%]YHAR'^40]"<*(1V8#*
M*EQ!O4]<(A2$!T<FU"&/77#B$6>$BB'(<8]<<&(1H."X?B2!C56L=A<\?PH[
M)"$-623B$H(PZU-4$0EL=*+[L#!D, K!#D=T7Q:F_\<?)$(KV,/A0<4TV,$N
M9$,^D!Q4X(,=$((WY /X/44ZP $FG$(^/!94R$,M/ (Q4,(E-((R0$4ZF,(B
MH (I7,(E6 -4+ ,E1,(P+((GA(+4*00VO,(D1(,E7 (@O)U"I,,M;,(<<($:
M- +2_?^#,1S")7!!'*R!84&%,H0")U0!&;2!+40%//C"(QC!%_2!+YA=+'#"
M)2R")0@"0;!>+UQ"]S6"(-@15/S"&"["(PB"\CU%/FS"(XRA(QQ"<3P%.)"#
M/]1#/FP0I92#C=G:!IV?0MP#.: #(M8#[/W#.Y #V UB/1QA/:C!)4S",?S#
M,Q0"5*2"'UP"+^S#/VC"@OC-'EP"(AC#/\0"62C$.W3"&Q1"+9A#.61"5#@#
M(P0#*$B")QP?5, #([A"-RB"(;CA4_P")E!#(%S")MA#5'0#(S"#+X3@" (>
M)Q#"( S"$4A":"E$+53"(42"(2R!(\0#5'A#)[Q@)R2!(^3_QU-0PR?P0B0X
M A94 C= A2JTPC\P0R-< B' GT)D0C^0PRMT7S P("Q@Q#;L(""H(Y;(PQ_\
MPR, SS](@BLJA"# PCSHXC\T R0\13CHP3\PPA->PADJA$F2PHF)UA4^11DH
M R@X@D*0 B) 12-X0S,$WS^@PB(\A3_0P3^\03(HQ!\XPU.8@QC\0R&X(21
M U3\03.<PB-P B , D$>PR)(0RADPB9@PBU A32H@3&0 B1,PB#H0N+EPQI4
M0RMX0B$ 0BAHX"%44":@PC]0@R1 Q2U$PC\X BD(WQI A1_, S^X@>!L0DPJ
MA!I4"!JDG"]DCT(X@B@H1"48PRP,_P+@]8%"[,,CI(,?F*)"@$,>-% Z&$(_
ME$$J%J59\0,DO,,BF,)3'$,>$!([*.93)(,8F!X]F('F_8,^F '2F0,:].%"
M" )4@$(80"$1_,$E0 (D9((_ EX5Q $G2&<F4.8_Z((29*=V;J1"B$(3&((A
M:&<T0 4F4,(_] ,HR,(W*,)9D4'MG$,L[(,E[.-3N(%6Y(,O) ,OC*66J('?
MK (Z\ $4AD$TO,$DW)$?]!!8A$$Q%,(;*$0>D.8_]$(D>(,1U$<Q/ )4P$(C
M< ,9*% UU %4C$,<Y $W3,,8K()X_L,M6,$A;$,IV,$P!.<_=(,08,(TB((5
M#$,^0,4W&/]!)V@#,QQ!-W"=0K#"+( #@=9-E"J$'_P#)6S8)"CC+?#"/WCF
M/_A#'F1).E1!-*R!-X!%)JR.0A!"'Q##')@#/P"#)2RE%4"#&M3"/Z1#(F"D
M0J2!*5@">ZY#)>CE4ZS"+PR#(I29)<2B0N""+B1#&9Q#.R""[_S@)U3#()#"
M.WR#&A"D.%2"-9#"(+Q#-6BD86J>.;1%< (#*"H$/ !#:TI#<RJ$/GA#-!!2
M/IBD0I #,4"#Z:D"*8P#)]#".[A"@SX%, @".41"*+Q#-(SD4W!"-<##&NP#
M/2S"$RJ$)D2#/+3!-KQ#)(3C/P0"(;R#/!C",MQ"3EK0&5S#.W#_ R>0 Q](
MHT*8PQI0PSL80QB\@R1LEF,&PSN<0QW,HC).PQI<XCNL@S?T 2&=PQWLPSLD
M+#7X00V.PQTXPSHDK#.< ;W^0RXT0CM$[#WL B-$Q388PA%&!39(@@]2Q2NP
M FG8 B:,1BWL0N19PQ[H:GLFPCGLB#FX A5HD4(TPC;LB#IX0Q2DPE-,@R5(
M'3X4PA% Q36\ 3TH@V&=PQ\@G3SP 9B1!3K\@<N5Q2ZPCCV(@RIHPAMN O4X
M S\<@T^6"2+X0R<@YU.,PR&8PCY<PE3\E2J0PZQ&13F4@B^\PY0^A2Z<@3"(
M03BHPS" Z%,8 3!<0@710R.DIT+\ AXD_X,;W(,Z6 .T8DDTB"+,ZH)4"N4I
MA (;5%DD'"$RI$(? "8MT"946(,K& (G_.0L*%(V$((1_($E$(-4;$,LC,$<
M% *C6M O>((52,(@T)TDBD(G $$8,,);-&#DY=SJ@1Y!3D4Y,"GW(L,G.$,N
MA $EU. =&<,G3$,JA($CZ.@]]((@@&88B,+GK<,O5,(Y,$(8^!]4A,,KA$$F
M4(,]B$(D/D,BA $@I(,W9.-3V,,GA,$DN$,TL"!4N,,FA,$CH$,S,(,A)4,I
M%((B?$(J0&A&J((E9,(ET$++VEPM;()TEL+VFD,VL,(B2 (C7%]4Y,/U3L4\
M1.+D)8?S1@4P2/_D/Z1"+*1H8Y8#)WCO.]1"XEF"/"H$-?2(-,PI5!P#+L@%
M(XC'TE9J8PECO>Z"1%Y#)4P@/XP"1N9#)Y PX/&"$E2O5*#"'%2D: S#&Y#!
M:'S#(T1M5%1:+>P!/)##(#1=,WA#(=BD*QSO/7C#+_C!,O3#]'"6A_0#+BRD
M0N"#(H'"*7@8//S?/P0#+H0&.FC@/^1#+6C1VD4%.H""?H(# ^_J+WA#S?&#
M,AA2DE6O/F2O,5R9!3GO#O7-'0TI5'3#+0CS.)3=/]Y"B3A> 79<+0 #R0GS
M4^C-)KOJ#O\#+(2R0D#B,,J"%IE#QRI$6/3''3GO/-Q",8"#,+S#*___@S#4
M CS@PS*T6%18@RQ<@S]\PSAL[S\HPRU(0SI,@\=%Q3VXPH+P@_?:QR\(\Z-!
M13^X@N7:G)<4@S? PBF< BB(@M"A0S  PT5C]%$^139X@RA<M":7W38< RI\
M-"C,0PL>0S"P=#CO S!XM$DS,!15M$FCPO\Q TF;-"B@]#&4-$:#@B+2 RH<
M TM'M,\=@U*;=#<@$C%X@RF8M"B 7SUT-$O'Z#PD-4M3 U10PT^;M(X:@TJS
M].K%0TVS-!'S S3H-$8'PPZ/-%%K\A&*]4J3M1VV 2+X B7@W!TP(#V$@2;H
M B%4R!Y4WC^4PR<T0BD$PO&504C_@S:<@2[P_\(JD,,RH.A37(,?[$(LA((^
MC,,>0(4^Y $@^,(AF.(=7.\MM $I! (MB$,I$ )4 (,?D (AC(+".JY"3,,>
MD (O^,(X5$,9G!XC)$)LGZDGZ*="Q((:Q+;LZ-%3U,,?!,(K4 ([\,,=D. ;
M,$)LN^(9!*<Y<$(GC (B] T?P#$S!#<ED,(2]>53.,,>O,(N[((_R(/._L/7
M(L(K\$+QW $AS0(?Q#99Z,+8/H4HZ(%NCV4P6+%"",,9D (EC$(Y),/?>N(>
ML$(L[ *55>E3\((D&#998$(6N^H:',)_VT,Y='>6-,(0',)]A\(J:& \(,$;
ML,*,K^1"$ $BS/@N-/_S*$0!)MSW+H1"V(YG$U1"AQ_Y*T\#%UQ"DX>"OZK#
M%%+"C)-"TP$"%_SXD>\"I91"$Q3YC"=Y.^"!'.CXD2OM4_1#&QB!D8="[K+>
M(B !EA\Y*<#>-21!&*AY*(!Q*0N!']CWD>>&X49!),2Y-/_#*33!)L2YFBH$
M,BC!(TPY!9=&(BS!G8>"+DQ@)&B!>AUY+)!P+B"ZHB^CW@H?*6A#'3 @-11F
M08P",JB!8ML#&BC$.MP",WB">'9"7/S#,HP"*J1ZDZYK/)#",&3X*7B"0J"#
M+K#Z]=Z!S!7#+_@"S#[%&P@C-=""+*#M4UA":#G#* 0#L=,#'BA$.>!"-%3_
M+E28 <>)@C< PHG_@RU\@D+8 RD@0X4^!3,@Z#^XPR@(PQL$YSDTI22J C-
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M"49H0A#D&]H_IM$')_#"%Z3( M) !XDP7*(0F9#;1%BAB7&(8QU#6<<G+C'
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M&N*!&=YL':IA%_S #GJ!%A6B'2;A$J[K'R1AZBA!%1^"??N"&+P&GV1A$88
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M'$:A$!"A$-Q 17-K#T1AMHEA#YI9,T;J,G:A$2A!$OB@M%%B&<X &F8;%?9
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(E2Q;G@P( #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_008.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_008.gif
M1TE&.#=A00([ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
M    00([ 8?O[^_____W]_?FYN;.SL[>>RG.UM:EI9S>:R%S4HSF[_?%Q<4Q
MC*6,C(PZC*6<E)S>:Q#W]_^]O;VMI:7>WMYS<W/FE&NUM:W_[_=[>X24E(SW
M__=KK;WFO9S>>S'>>QE2:YR]:^:,I1 IC*7FA$*]8S%"E*V$.IP9<UI*I;6<
MG+UC2I2$:^;FK92]I1"<8UJU:[52YCJE[[49YCJ,I4+O>Z52YA 9YA!2I>92
MI6,9I6.][W,9[^:]WD*].M[OSADQ8YSO0J7OG!GO$*6$$)SO<][O&4*]Q7.]
M$-[OQ5)2WN9*4AGFE%(0"!GOWLYC2H2<Q=9SI=Z$8S%SWK7FSKU28^]2WH2]
M,5I2,=Z],1D9,9P98^\9WH2$,5H9,=Z$,1D9<QD9*5H9"%KW[^]K8VM*2DKF
MSJ6]M=:<Q;6]G$*]:Y3O0N:<I>:,>[7O&1#O$.;O6D*4:Y0Z,3%2G(1[8YSO
MI=[O&7/FK7L9I81SWN9**5H9E.9*<QE24F-*"%I2:V,9*2GO2A#OYM[O6G/.
MYN8AE+TIO;6,[Q (O;6,SA"USMY2,8S%E'.]YN9[E&LI4EJEG',(4EKO[]Z<
M[^:]<UK___<IO>:][Q (O>:]SA![4A"].JU2M3KOSN89M3HI[[6,[T*,[X2,
M.N^]$*U2M1 9M1",Q82,$.]2$*V]<Q 0<YQ*$"F$<Q!2[[52<\Y2[V.]$&M2
M$.^]$"D9$*T9<\X9[V.$$&L9$.^$$"D94BG%E.;%4F.].HQ2E#H9E#H([[6,
MSD*,[V.,.LZ]$(Q2E! 9E!",Q6.,$,Y2$(R]4A 04IQ*$ A2SK524LY2SF.]
M$$I2$,Z]$ @9$(P94LX9SF.$$$H9$,Z$$ @94@CO]R%KE*W.YK6]G+WO]V/O
M]Z6$6KU2,:T0C*5*,1#%G*52<TI[6E+.SMX0*0C>[^_OSGO>YN][>UIS4IPQ
MG*7>SMXZG*7O:Q#.Q=:4K:5[G(SO:R'O]^_>YM[.SJW.Q:VEM:7O>RGW[_=[
MC(S%SL[FYMZEI:T(_P #"!Q(L*#!@P@3*ES(L*'#AQ C2IQ(L:+%BQ@S:MS(
ML:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-FSASZMRI$ "!GT"#"AU*
MM*C1HTB3*EW*M*G3IU"C2IU*M:K5JUBS:MT:%0!/CP0J<!U+MJS9LVC3JEW+
MMJU; @8F2/C:D4 #@5[S!M#+=Z_?OH#_"@Y,>+#APH@/*T[,>+'CQI ?2XY,
M>;+ERI@O:\[,>;/GSJ M!Z#0CRY'NP!2JU[-NK7KU[!CRYY-N[;MV[ASZ][-
MN[?OW\"#"Q].O'AN G--:Y30P+CSY]"C2Y].O;KUZ]BSIZ:07#E&U-K#B_\?
M3[Z\^?/HS?_TGA%\^O?PX\N?3[\^<>3LOS>WS[^___\ !OA< .OE9Q%S B:H
MX((,-EA?@5^I-I!7>!E$884#V;67@QQVZ.&'(/)&8'<[ 3#! PT08.(#<U'P
MP ,49/ABC"=.$(% "(:HXXX\]L@@A'1-4(\$! 2@ 04'!&#/70%$D&1<!LSU
M0)$$[N?CE5AFJ:5XW"F'WP0&! #C WN16::2$WQ9I(E64K#=FP"X&2><<M9)
MYYUSYFFGGGCNZ6>?@/(IZ)^#!DKHH88F6NBBB#*J:*.0/BJIHY1&6NFDEF:*
MZ::7=JJI(.@,X!.)/$T0HSRG&D F &:RBF8_<^7_4R0Z$^RGJ:><WJIKKKSB
MZNNNO_8*[+#"%AOLL<0B:VRR?X(J" #J/.L3E5]%\,"-1(HIR01*:B!0/=Q2
M@.I<:0KDWI;HIJONNKOA1Q>X>-48@*I3$CCOB^X$<*(\%/9C);L !RRPNA@
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M@#TFP"HJX2^"*!18]VQ" 0UP@UPQ>H"JSG0F"DP 5OHR80.XEL(>=BQ].:%
M!?_L<8&X%.D +J*AJVR(PW*YR%9Q<A,%I$C%*%IQBE>L(A:WJ,4N9O&+7 2C
M%\-(QC&:48QH+&,:SZC&-K+QC6N,HQOE",<YVK&.>*2C'N^XQSSR\8]^#.2<
M)NB2+B&G'S&TX5XZ"( DC=  12K7D++GPTH";(4V(4 ^8 0 >9RH'B%DH %
M>:)^1& ")SI@E2S)2HD!42?NH) @#* P \3(+P2Z)3H,<"'?M?*7Z(J  4)V
M/>(!\YCHH@(^2,6[^"'SF3ZB CQ*T#?U41*:V&P0$SZ  &:ZSH'9#*>'/%"
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M)V4!V><:^E<2<Q: (;@]]:!\7>: -:5I+5!J(PAF][=03,!\M*$ V]<1]-8
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M'#54#<T:>=95*YN-)*#=U2$(?KA;&T7D<1G6",FL.F(P8U )8Y#E6Z[E61X
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M57ZP(5E\%]\[PMT1(0$:P# 4T  2H "1YX14<B+CZ"_8BA#_0&6[W+!71MX
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M*$9@MMEF32 4$ W(D"/9 &:T-@ -:!0RR)8HF" ^"29 IT@550+@7 (F2"\
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MN7DH(Z#]G21:P*H*:LH=8GT(G< ,,A6PCS'<E*L[,LR.!0S@ <0UG#IB'9$
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M_Y@XC,:<"=R\S.+DB69+1810-&1K"_C2C=N*FS)D@N7$#Z0+/>)*03MAAS9
MB'KH!)-H@WKLB;^\L">(A\KD",;\S9RX@)]I,<#"/<U0 .(TSOKT".^!%1+
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MU>>K]22SPA.$ %\0"S/N=,9(#CK_Z(CBHL/EH_CE>4Z!NC Q$V  !A!F,)6
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MV,X42 %M. -M& %&YV@.: 2V-C%C3QE%,( HF&<&*(1V2 %.#0E)E4K!7,K
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MJ-,3N!& !RP"/(=[@@K.$(^!*(XVPSD:?+KW$$E,;"<>HPK %E20X TL(5"
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MP0!'H5SG=)(NI\0+F3R%0C@>M9_Z'.=E3G64I)QB//M0+C<XO)D1HV"\@IB
M ZQ!WIFP>A,ULK.LKGIC_SS3"C(%"-!%H9%$!\R -<HH!GX=\"%%^9>MA5[&
M @XQ0Q\7$ZP'ZLH#[N&8.UI7.W:L@!'Z>)\E=Q* .J%DI-0)"54&,I^"J*.E
MLW(9EK@4G-"FH!$!^-U#3EN]=K#))LV!'@ "H C@_ <*AMIE<XI3'WM5"ESG
M'$A"]!/-=G  '=PL#E%QB(X;@K4AZHCE>RB@%:!,SBGM4,<[<8).=9JUNQ<B
MGUK#.ZM[NM5%)-"51W5D&2ITP )WT)]-1,2$LU'&6FT%I1.<8 ^<F*%K[EE
M14K9G06TMP45O$D]SA 'P)52P!Y,P'E\FA"$]*Y\  /.Y(QGO-^)$PK]F.)5
M&__"@7;,,%*54Y0!&N$X<$'!( 2B34XH4#,U 6>S!AE!:UWK'Z DA"#&6QA#
MQD"!H[0C"@;PEW/0",,-,60 6JUE%#S[$+)ZM\IL0:MXL^P>OW1@5_A4;T'I
M6J* 1L"<$(E !U+AY:W=H44O^D#^+&KFAI#9+KF+@"#:4)Z26F0%&@RH3=3Q
M@#8\ !W<6"R$%W &D&0DA$%,UU"*S '?RE),E'.<I!:6J:%$)=(F0$=SH* ?
M<-JK3=3;3PKZ8TL&4!,I6T3J?ZK7XB?1QF80L91]H!"%K$BJLPTL6E*DA@$T
MO(8!0)Y+.JVL;+7 *JA:?G9<%" )]C)!6\8J@&#ZJ2/_PY:9+NTE[Z^J_2L(
M1%8G%95+[C)Z&HL\K#K@T0BE';* %2R"#DCJ#CM>5PE!C*<-#6M#' ;48Y_!
MMGR$B"5# H"!W(VA'U@R#L_.Y-/C*(X@I/,=CUFC$ /\AZJY<4"\T(2>GA:;
M9^JP(E:,G4()UT<=1(-<P9<L->QM]LATH8#2EJWSLF 9VC[/B1.H,"VMI8T)
MT!($.@:YM0*TX-S1QG-EZ%L $E@ I'3)72>?\Y"/X/MB;3!'G\Z FI(X?;(0
M9BR[Z7"&FBC '0M@GTMT2URQGJ^($.$ -;/TZ4SMU@"[OC$4 B F,MFG/IG+
M"@5./A3D20IY%/6JS!@0#N5:_[=Z*0 U0S(7W!10 $QVA^,87.:4$X^2RCL_
M/7A_KOHSN[FCF(& 'EN0B@+X%3*S!Q8)K#45?ST((A8@P1V,_J)"6E0G6=]8
M/=3A#@HL?V/,IT#N ES9)RSB 32!B[\ !^&;..P[M7N  CJG\(?8(RLXSJZ6
M=]W4@2'/((5( 7& \TW-<Y7$+B:(YCPFB*:\&#@I^*9!K OE]$0*W,8,==4-
MM08#H &TA=YK3-KQ346RG1X%]MSJ:=FM ( ]^4HC=51AZ$D$08#N < D-50$
MPH7'-,=I%8T*- (ZN$1Z8%)"\8HE.1T Y([R080[J$!&E(>_ 0 />H<*/$!,
M+%;K</\#=KU6<X $A,U)0[","I02=:@ W4%$)2@"-E78S[6,\[3:?\1&4MB#
M9BT(X16@4SC%NH18  "7+7&)4,R?BM44F*"#09!A'9K Y"F9>&$ (>1&%*"?
M3J!3SE'@SL&*'E[@U.Q%!CK$^MB-T)%(D&2-9C !":3!775&QYB!&232G544
M7-P0*'* BL'+% U,")V9(#'&"#X'#@98&PA" *!#12Q"95G$H-6BDEB,"GQ-
MY&0'*-H#!8S'13A$   8HSW,8@G"(;J63VCASX6>ABG.$T7%K[G?<1"%"=A#
M@B0'5RB*?Q0>Q$T8C*E030' &-J?BRF"#:J5.NP'&CB;!'+_%R'JG 4B8M1(
M6XV0#=L8"_!AS0"-6[ HP ",06<\Q@YBUYQM#,  !6W]AVCYAO&, !" A0'E
M3I!X0#V-1CT$@ ( V&753AMP VJDA/:A';NQ&WB !0:L(!2@P5(-C'V 0 *P
M!S!]!X1QPQEP0[S=%*BI Y<P0#>NWKZ0F#8T@DQQR>351$\DQ),@3R/X"_/4
MVDU9Q10ASVPDA.:<RN<9D_'<!T)P0,R)%RS9!80,XCPJ&ZQ$H#W.BB(JP!@(
MT(D,AEMES=;0#=-="T-4Q FP0\1HUW)UW&[97TR1(0BL1$YZRF>D A/TQ0T"
M -@]@&6QFW6,5!L P *@Y,.T 1W0_R(,5$+.6,H(A$/'S<=5R*0&4=9WN$,
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M-@C3&6A%%&RD3Y6B^S'>Y/A?06B$]I&4!@55BD[75G"<8&;3D#:$(G@)/ +
M[T !(2QCU/044$"!IU;J@?PHD)I5/9*J72B (,25&5!!U;P>U:G7>CVI$]B-
M6W9&D/6'-M"I\\S4? P,-4W5-]&I=]BGV@F".[B# ER?(FR>;H"  ZP =B26
M>.Z63.D&F11"?-Y8*5K/&M;'"*"!J%5/K&D:!EQA% A$;( '*E'_(3?I##$"
M5S02#(-\&JE6 @OE1 3()L@8C+^2JB">JI6EI:KF!:M: &C0PZ[ 3V48QAU0
M0=[8$Q-T0)&ZY6E-3N-I@S9,T5"0)H8*)C@Q"9U>A K$@2JI)E6T"<D9QTS!
M) BH0#R4BXL%ZPR-"58L#E%87!A%T:. 4Q3<BUCI:QDY $JZ PR%2G"\EG3!
M5'[(AE;EU,%.+=4BC3P2+*I&9]7*A2"8 ;7,R$+!C\1VA$6%17^^%LN,P0",
MD;B6HL9QR9H@IZ-HC_& P'K$ P ,@#LXH6MA(2T%%P@LV)C6(:MA25$H@G3Y
M7QOVK%<FQ#>)RL+0*$X8A0E01V5J!R$P_XXST5*4W(?F' 7I;:WHVN/ 8FUW
M">GHY@2K4L%<+88^% 8ETHT9>$Q[&( !3&CC/8 PM0$(".;'WF&14<#"L6T9
M%2AM<, 9*((@R"A!MA3V3%7]=:O]Q8NE\,R7R-:A0@GRR-9/,$B&-46.'1A$
M\ P#X DWF!J6'*J/R<L8V68*"%DCI*[\VN,$FFY9I6JE9N#Z\$5G" (=40ME
MP ,E:(,B$$)_9@KR*,(92 HV+=5_V&?>M4-ANE)]$$\C]$ML/2M2V*X[U Q7
ML(P1\5*1$0B!?M-1H*O.**65& _G@4FZ;!6(:4J([<12U$>?_0/V/:MQ<!J/
M<1X&($B%;H7,S?\O$3>@Z=EO&QDL6_*OK+!J(W8MB=R!PI( >TDQC+R(/L"#
M!SC".PB/Y@S$MT[5R]H8X3% %.SKR5&)]#R$BG%3=C G:=2,)*38KKGL4&A.
M#RWC&*"#XX35R&#:FE"4GNXD3Z@?GF!'YU'/_\%,%AD YXR!"LQ,P!8Q)9^/
M<R(Q.^%O7.PO8]K$7]0(E*[/ $@"WZZJT&G+()T(DJ)(DNJ#!ZR#(\P!B:W:
M%&4)0MQRK+6#-FSK3W6>4H;E$'M("GX,S\0&!W#35"@A<Q01.>Z> ;!:?)[!
MVD;*B WK5&'70X!H)6^S6ODH)K,3ZO(/1'P-8WX-.@@"!2A& B&2373_  E<
M)VA@) F0 )3FQ/XV1%^466?82",E:;30Y64D2PG,02$4]/]-%8!DQ59%!::9
M SKL6E="@:^%UQB@P1=QR6^"GIAPZRIA -M2%0M' <WP!#>7M'A=\C>?A7:$
MQ4J+Q4JW-#I%9V>PUZT"@#K@PWEUP-S@3[51 F8@B\666=ZT+C[-G@B:$ZNZ
M<[*$$ESI-"*9@</J0P&40 %(M0>0"&' 0P%H=0%0 @BH!N "01M DVR\3!0@
MR V="N^]EC.]J)81Y+,FUR3+RAB80TS.) 9$$U+4##I( C";-&##4^FFM%@\
M@#H!P ,\0#Z@4V*?25@L0&+?S@0\P 3$5@# _PJ@F4&U::<'I &S5 9=IH)4
M%Y1':6('"!VR7 8]5#5^=9N(N#-=-H8%J')F*$L)T $(\(,CK,-TN4(<4((C
MO  7V^=%M(Y(3 ![T(LZ#,"W,.=61LZHQM,>\PP4=!X\D1RWTL$-=>7 ^/)<
M!S9X2TW]$C8%-(#22( Z-8 @R$, 2$(#L/0!G-8$>+-AAX4YK .LV@A]T9=D
MP,-HEY?62")54\(Z@ 952]2KC@A1WX_#DK8^.,+'DIA^4%-KZ,>8<D,G+/>W
M ("2>=YW/]L V L@E@\?P@L4J$ M<YJ^A#>+9]E@$W8 3( ZS7>,F\,#9,>-
MX_AV3$ _*(V,AP4!:/\" B# [%WQ8XTV KCR"]  )?CT!VCQ',R!3P,X/#B"
M"1!TF)[ "XRV98!&9E!&"93 :&MQ/T%XRJT?@S"%S'Y-/62J_.I:/X17BM)&
M$S5/R+4XGJO5>!.V!"C- ;S. U# C2,V2]\X.LBXTN2#.@FZ%+AN90!W"5!"
MF(>Y(WQU%(QG>;Q ";S %SF"5O,* J3!"V#Y_Q4T/X29B[Q  HPG):1!I#N"
M SA"%GN 4+!PT6P*J?B8?736**N#()SI.9^SKP^[)*B#)/R)/0B"L2?>L9.,
MLBM[L_\)!3P[!3"WLD\[HER[MF<[MV.[MV_[MW?[L^.5L0\[.EL[MZ.SKTO_
M.[17^[2C [8?NZ\#(SI/^[?4>[W;M%' 9*ZM2;$_^[*W>[L[.[Q?N[W?^[<<
MO,+7^\(G/,,_O,-'/,)/?,-3/,1;O,17O,9?_,9G?,)_/,B'O,B//,F7O,F?
MO,D#P!&G-(]?MCH]@#TL-@5H0%C4PP3(MW/* W<IPA=HM650PCVH ,>V 1O$
M@[L03]XN0#RH0!O$2<UH &7XM!8+14&L"U.V R4\N6J_ &X["A@AA"-00@48
M@FW%$@;P,2'HJT#LQQE_>)X+2M-NEE DQ8V^O=U'S9ZG-'JCB3Q0]G8DMCJI
MDP$T=HQ3]DH&@#E(01HP B5( %]@@%OR7K-& $TT_^M*XG-8J  "P$,:C( C
M;#%P-,_DW+(#\$,%4+4 \X/,D,G<ZL=0( 4&T(2B?$SD/*K-W7T<"=E0R)0)
M!"7N__[4O#B,C\5&UGP$U#SRBT7QAX4A%JG;$\(<5( #Z"A!T(R>8LYT$43@
M+D8%>-I/WG)"] -[IIH+13?PWV..3F^PG3_[0TW>#_]9-4"S)N2@*$ ;F,#:
M,8]4(%D*)4B6] 9 F"@T8D2*=E 4*>*0 LH8 %!,- 0PD6)%BQ<Q9M2XD6-'
MCQ]!AA2IL1(4!B;:C9 XDF5+ER]AQI0YDZ;(  0D!-"YDV=/GS^!!A4ZE"C1
M!0T<RE0P)NF I!:9JD-I0O\@2@8,H9A#!X!I3:]?P89U.89#.P;M4BBJ))9M
M6[=OX8(E0*!H7;MW\=HET"#"S*=<-XY)0; =U4+M% 48@R%N8\>//8XAE((!
M T5_(6?6O)DSR)LY\X86/7JHA :0QRB"PH'#" 8<###N/)LVV $I4D21A+EV
M;]^_O\XE/9SXZ+UK'S,-8, @E # H4?_:$]Z=>O7-7XNOIT[4=.=U:G#/KXZ
M;_+GT7,6WIU]>YU[9YM//Y]^??OW,VIWOW^[Z>?X 0Q0P $)K&D]_A T[K0"
M&6S0P0<%' .G!"D,[3L(,<Q0PPU[,X"N"D&L"SX.22S1Q!-GTB_$%8/R#\47
M88S_4<:)#F311IY&G%'''7DD4,4;@;RPQR&)+'*\&H&T,4<CF6S2R<TF3#+(
M!OY[TLHKL?R* M"D5'+!+,$,4\R/?NPR1"''3%/--)$TL\(EUXQ3SB;+=)-"
MTQ284\\]AVS33@3WDH_/00G-$(,H_ZS0-.0*;=11"#U,%$0X'ZW4TOOJ0512
M!-&\U--/SW.'RTWYHQ344U'UK1(#1B75/3Q3C556VOQTE;M 9\U5U\;&8-56
M_ES<5=AAP3)@@5_W,Y7899D5:4MDBZJD1@ (H$ G"@@ 8*=.F^W6VXT(.!9:
MH2HY8X('N)3@W&PG.-?:F[[\5MYY*7IVW*#J>2" >C30_PD ?>UYP-<)/MRK
M2GH1;O:F#^\%JM]__=47'8)S(O@Y"2HPIUH"#'"'X[FP[?CC:C6FP,.-.?;8
M0VRQ37EDEN<2^623508Y9G-:;EGFC76NF>>8?:;YY9MS!OKCD&UVV8">7]X9
M90-*?CIHJ9M.>F>DGXZ:Z9FIGIEKI3?^&NJ?P:Y6[)JQUEEKH[G>&N2SC[8:
M[:$YCAKNI>6.VVD*2KX[[*#MMGKMLH46&V>ZQX:9\*[?GKKNM*.6X(*&@8(8
MXN?TI8#B -"@:\L*VI5G@@,F$+WT#$@G/?0#6 <]]'9';[>!!DJ'7?7203<]
M]M!!OUWW"69_O5W5@]?=]]QMA_]=GMZ5AQUXVFL?7G;HHR^==->M5_X [*L?
MO?CD0T<]^MLGP-[XZ9NW?7;=Y2$?>>EA-Q_\X(4?_GOXVW6=?=4UH/[W _JW
M/^=50(#QJU_[VA5 X1'/?\Z[7OJRA[P'@$^!OF-=_PZHNMR1KWT'>$ #?&>[
M!_"#=*;S708>$,+XJ7!X#W#$N<!WN@F:4'DH9&'Y+%C"=5$.*/FP!P'TI2T?
M]F,"6_K7N_8E%&T%98F5&TH3?P)%O$C1)TC\B15],A$F4I$G7-R)%^L"Q@!$
M@#\*$(H9]X/&RJ%CBT+!8D_4\40E"H6-3!S*&,XX1Z&0$2AK$8HDZ#@4-491
MCT[D85[_!O  >0#2<Q/4E@3010%K >!<4)3D<SS(QYT4#%T]L8<!QNA!*?:#
M !B0QP/<T9,(3. FBNP))0, 25;VA)0!>, #&*83">2R)[ML$2]Y,C%-_J1T
MB9PE3RKY@'SXQ "X!"(H>=+,N3P BQ$X90KEH4H/*O*8F[RE!WD)Q!0*3)OC
M/( 4Q>G!5J6SDSTYY3;%N"(*3/!:5IPG&NH9S0?@,P"71"8UW].3>4Z3EP-]
MID_^,8& =5,G[9HG0_T% &Q1L2\*J)84^R(A"@QRC!,9P *@2*V&'@"+V>HG
M/7&DK8<>TCT>#$ #) !))-(3IOW00!UU0H98H@L-W3S72R5P_P8-(+$?%:
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MB$X"?4 7574RP7Z480)H@.]SRD"&!O^000Y&1:8<'-$ .?QAL1, L(#)L-@
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MA_>R)X [W''[36XZ6R7=] (J@476FTS[NDR]%"EPAB5.O]?)'SUIJ#67F!+
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M75_TTR0@E4!UYT@WBU(OB]9!*' B'[CA>6?G>E\) W_RBRH 0;M7;6_4R_[
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M /PT8.V,LOWW\/*_\SNO 7X?">3010K_U-7?>^9AY<@ ^37T$043A(78 A4
MYAU&[D"8TG.:?0ABB!^:(XB("PDB@03KL;<BB.JDV.)"OIE(08J2V%1//R8J
M-  :$MR(4@0%[MBCBD+-:"(!*0I%@7L[*HGD110DB)F2.MHTY8X%68D!EDZ:
M")H$"3:I99EFGHEFFFJNR6:;;KX)9YQRSDEGG7;>B6>>>N[)9Y]^_@EHH((.
M2FBAAAZ*:***+LIHHWBB4<X??9 194$37.=HIIINRFFGGMJ901.BB@H7 !0<
M)D$395!VZJ>NO@IKK+*^VD 3!TB23Q-R!/" '.< LD 9HO8!0!_G-"'@K,HN
MRVRSSKY9*UR GYP3@'VAED&!JI6LTP1AW3X+;KCBCDON0[7>=FP !I0A1Q-]
MV(-L .U.VX1?Y=Z+;[[Z+EHK&0>0T81(QQJ@JB1-_!$ P =P4\$"^SX,<<02
MT^G(J+K:D["N30 BR+&&R3&M'%1.3'+))I_\T0 I2O"E!/9(XI#*"54B@<,H
DWXQSSCD7I7///O\,=-!"#TUTT48?C7322B_-=--./ZUT0  [

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
